{"content":"<li class=\"n-box-item date-title\" data-end=\"1557979199\" data-start=\"1557892800\" data-txt=\"Monday, December 23, 2019\">Wednesday, May 15, 2019</li><li class=\"n-box-item sa-box-item\" data-id=\"3464427\" data-ts=\"1557960780\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MGNX\" target=\"_blank\">MGNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464427-macrogenicsplus-13_1-on-new-data-from-breast-cancer-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MacroGenics +13.1% on new data from breast cancer study</a></h4><ul>   <li>MacroGenics (NASDAQ:<a href='https://seekingalpha.com/symbol/MGNX' title='MacroGenics, Inc.'>MGNX</a>) is <font color=\"green\">up 13.1%</font> in postmarket trading after the company <a href=\"https://seekingalpha.com/pr/17514356-macrogenics-announces-positive-results-phase-3-sophia-study-margetuximab-patients-her2\" target=\"_blank\">revealed positive data</a> from its late-stage study of a cancer drug.</li>    <li>The results are more data from its Phase 3 SOPHIA study of margetuximab in patients with HER2-positive metastatic breast cancer (who have previously been treated with anti-HER2-targeted therapies).</li>    <li>The study met its first sequential primary endpoint of progression-free survival, MacroGenics says.</li>    <li>\u201cAt ASCO, we will also present data from our Phase 1 study that show HER2-specific T-cell and antibody responses in margetuximab-treated patients,\" says CEO Scott Koenig. \"These data are consistent with the hypothesis that margetuximab facilitates the cooperation of both innate and adaptive immune responses, an emerging paradigm in immuno-oncology.\u201d</li><li>#ASCO19</li> </ul><div class=\"tiny-share-widget\" data-id=\"3464427\" data-linked=\"MacroGenics +13.1% on new data from breast cancer study\" data-tweet=\"$MGNX - MacroGenics +13.1% on new data from breast cancer study https://seekingalpha.com/news/3464427-macrogenicsplus-13_1-on-new-data-from-breast-cancer-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3464427-macrogenicsplus-13_1-on-new-data-from-breast-cancer-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464425\" data-ts=\"1557960383\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RBBN\" target=\"_blank\">RBBN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464425-ribbon-commsplus-1_6-ceo-hobbs-buys-100000-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ribbon Comms +1.6% as CEO Hobbs buys 100,000 shares</a></h4><ul>    <li>Ribbon Communications (NASDAQ:<a href='https://seekingalpha.com/symbol/RBBN' title='Ribbon Communications Inc.'>RBBN</a>) is <font color=\"green\">up 1.6%</font> in late trading after disclosing that CEO Franklin \"Fritz\" Hobbs bought 100,000 shares in the past few days.</li>    <li>Hobbs bought 50,000 shares on Monday at an average price of $4.808, and another 50,000 yesterday at $4.863, <a href=\"https://investors.ribboncommunications.com/node/17716/html\" target=\"_blank\">according to the filing</a> -- more than $480,000 worth.</li>    <li>Hobbs beneficially owns 317,930 shares after the transactions.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3464425\" data-linked=\"Ribbon Comms +1.6% as CEO Hobbs buys 100,000 shares\" data-tweet=\"$RBBN - Ribbon Comms +1.6% as CEO Hobbs buys 100,000 shares https://seekingalpha.com/news/3464425-ribbon-commsplus-1_6-ceo-hobbs-buys-100000-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3464425-ribbon-commsplus-1_6-ceo-hobbs-buys-100000-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464423\" data-ts=\"1557959781\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464423-trump-order-will-ban-foreign-telecom-equipment-nok-eric-gain\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trump order will ban some foreign telecom equipment; NOK, ERIC gain</a></h4><ul>   <li>President Trump has issued an executive order <a href=\"https://www.whitehouse.gov/briefings-statements/statement-press-secretary-56/\" target=\"_blank\">banning American telecom companies</a> from installing foreign-made equipment that could threaten national security, the White House says.</li>    <li>The order instructs Commerce Secretary Wilbur Ross to \"prohibit transactions posing an unacceptable risk,\" and while it doesn't mention one company or country, China's industry leader Huawei jumps to mind.</li>    <li>Trump declared the threat to U.S. telecom networks a national emergency.</li>    <li>Also likely affected is ZTE (<a href='https://seekingalpha.com/symbol/ZTCOF' title='ZTE Corporation'>OTCPK:ZTCOF</a>), while beneficiaries of further prohibition are likely Ericsson (<a href='https://seekingalpha.com/symbol/ERIC' title='Telefonaktiebolaget LM Ericsson &#40;publ&#41;'>ERIC</a>, <font color=\"green\">up 2.6%</font> after hours) and Nokia (<a href='https://seekingalpha.com/symbol/NOK' title='Nokia Corporation'>NOK</a>, <font color=\"green\">up 0.6%</font>).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3464423\" data-linked=\"Trump order will ban some foreign telecom equipment; NOK, ERIC gain\" data-tweet=\"$ZTCOF $ERIC $NOK - Trump order will ban some foreign telecom equipment; NOK, ERIC gain https://seekingalpha.com/news/3464423-trump-order-will-ban-foreign-telecom-equipment-nok-eric-gain?source=tweet\" data-url=\"https://seekingalpha.com/news/3464423-trump-order-will-ban-foreign-telecom-equipment-nok-eric-gain\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>74&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464419\" data-ts=\"1557959308\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTES\" target=\"_blank\">NTES</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464419-neteaseplus-3-after-tripling-profits-top-line-strength\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NetEase +3% after tripling profits with top-line strength</a></h4><ul>   <li>NetEase (NASDAQ:<a href='https://seekingalpha.com/symbol/NTES' title='NetEase, Inc.'>NTES</a>) is <font color=\"green\">up 3%</font> postmarket after it topped high-end Street estimates with its Q1 profits, which more than tripled from the previous year.</li>    <li>Net revenues came in at 18.36B yuan (about $2.74B), with strong gains in its core gaming and e-commerce segments.</li>    <li>Gross profit was up 36% to 8.09B yuan, and the company cut operating expenses 1.4%.</li>    <li>\"Our heightened emphasis on online games, e-commerce, advertising, online education and music allows us to sharpen our focus on areas where we see the most potential for sustainable, long-term growth,\" says CEO William Ding. \"During the first quarter, we made a series of structural optimizations to hone these core growth segments,\" which \"directly resulted in a considerable increase in our profits.\"</li>     <li>Revenue by segment: Online game services, 11.85B yuan (up 35.3%); E-commerce, 4.79B yuan (up 28.3%); Advertising services, 438.6M yuan (down 5.1%); Innovative businesses and others, 1.28B yuan (up 5%).</li>    <li>Liquidity was 51.85B yuan (about $7.73B), up slightly from last quarter. Cash flow from operations was 3.39B yuan (about $504.6M).</li>    <li><a href=\"http://ir.netease.com/\" target=\"_blank\">Conference call</a> to come at 7:30 p.m. ET.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3464407-netease-beats-1_01-revenue-line\" target=\"_blank\">NetEase beats by $1.01, revenue in-line</a> (May. 15 2019)</li>    <li><a href=\"https://seekingalpha.com/pr/17514444-netease-reports-first-quarter-2019-unaudited-financial-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3464419\" data-linked=\"NetEase +3% after tripling profits with top-line strength\" data-tweet=\"$NTES - NetEase +3% after tripling profits with top-line strength https://seekingalpha.com/news/3464419-neteaseplus-3-after-tripling-profits-top-line-strength?source=tweet\" data-url=\"https://seekingalpha.com/news/3464419-neteaseplus-3-after-tripling-profits-top-line-strength\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464415\" data-ts=\"1557958093\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SRAX\" target=\"_blank\">SRAX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464415-social-realityminus-6_9-pivot-brings-revenue-decline\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Social Reality -6.9% as pivot brings revenue decline</a></h4><ul>   <li>Social Reality (NASDAQ:<a href='https://seekingalpha.com/symbol/SRAX' title='Social Reality, Inc.'>SRAX</a>) has <font color=\"red\">dropped 6.9%</font> after hours following its <a href=\"https://seekingalpha.com/news/3464281-social-reality-reports-q1-results\" target=\"_blank\">Q1 earnings report</a>, where revenues took a dive as the company pivoted away from its ad targeting and data platform for healthcare.</li>    <li>The company sold its SRAXmd offering and discontinued its Reach product; without $1.86M in SRAXmd revenue, overall revenues fell 72% to $0.59M.</li>    <li>The remaining verticals revenue rose 132% Y/Y, however, to hit that total.</li>    <li>The company took a net loss of $5.8M, which included a $2M charge tied to warrant valuation. That's vs. $11,000 in income a year ago (which included a $3.7M benefit tied to warrant valuation).</li>    <li>It's reiterating full-year guidance to revenues of $20M-$25M, with gross margin of 45-55%.</li>    <li><a href=\"https://seekingalpha.com/pr/17514195-srax-reports-vertical-sales-growth-132-percent-q1-19\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3464415\" data-linked=\"Social Reality -6.9% as pivot brings revenue decline\" data-tweet=\"$SRAX - Social Reality -6.9% as pivot brings revenue decline https://seekingalpha.com/news/3464415-social-realityminus-6_9-pivot-brings-revenue-decline?source=tweet\" data-url=\"https://seekingalpha.com/news/3464415-social-realityminus-6_9-pivot-brings-revenue-decline\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464383\" data-ts=\"1557955826\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464383-new-sky-dds-and-vrtu-among-notable-after-hour-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NEW, SKY, DDS and VRTU among notable after hour movers</a></h4><ul><li><strong>Gainers: </strong><a href='https://seekingalpha.com/symbol/AGIO' title='Agios Pharmaceuticals, Inc.'>AGIO</a> <font color=\"green\">+11.9%</font>. <a href='https://seekingalpha.com/symbol/NEW' title='Puxin Limited'>NEW</a> <font color=\"green\">+7.9%</font>. <a href='https://seekingalpha.com/symbol/LFC' title='China Life Insurance Company Limited'>LFC</a> <font color=\"green\">+7.5%</font>. <a href='https://seekingalpha.com/symbol/SKY' title='Skyline Champion Corporation'>SKY</a> <font color=\"green\">+5%</font>. <a href='https://seekingalpha.com/symbol/LNN' title='Lindsay Corporation'>LNN</a> <font color=\"green\">+4.9%</font>.</li><li><strong>Losers: </strong><a href='https://seekingalpha.com/symbol/VRTU' title='Virtusa Corporation'>VRTU</a> <font color=\"red\">-24.8%</font>. <a href='https://seekingalpha.com/symbol/EDAP' title='EDAP TMS S.A.'>EDAP</a> <font color=\"red\">-17.4%</font>. <a href='https://seekingalpha.com/symbol/PLYM' title='Plymouth Industrial REIT, Inc.'>PLYM</a> <font color=\"red\">-9.3%</font>. <a href='https://seekingalpha.com/symbol/DDS' title='Dillard&#39;s, Inc.'>DDS</a> <font color=\"red\">-6.9%</font>. <a href='https://seekingalpha.com/symbol/EOLS' title='Evolus, Inc.'>EOLS</a> <font color=\"red\">-5.7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3464383\" data-linked=\"NEW, SKY, DDS and VRTU among notable after hour movers\" data-tweet=\"$AGIO $NEW $LFC - NEW, SKY, DDS and VRTU among notable after hour movers https://seekingalpha.com/news/3464383-new-sky-dds-and-vrtu-among-notable-after-hour-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3464383-new-sky-dds-and-vrtu-among-notable-after-hour-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:30 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464377\" data-ts=\"1557955594\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRQ\" target=\"_blank\">TRQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464377-turquiose-hill-resources-beats-0_03-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Turquiose Hill Resources beats by $0.03, beats on revenue</a></h4><ul><li>Turquiose Hill Resources (NYSE:<a href='https://seekingalpha.com/symbol/TRQ' title='Turquoise Hill Resources Ltd.'>TRQ</a>): Q1 GAAP EPS of $0.06 <font color=\"green\">beats by $0.03</font>.</li><li>Revenue of $352.7M (+43.6% Y/Y) <font color=\"green\">beats by $56.76M</font>.</li><li>Shares <font color=\"green\">+5.5%</font> AH.</li><li><a href=\"https://seekingalpha.com/pr/17514375-turquoise-hill-announces-financial-results-review-operations-first-quarter-2019\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3464377\" data-linked=\"Turquiose Hill Resources beats by $0.03, beats on revenue\" data-tweet=\"$TRQ - Turquiose Hill Resources beats by $0.03, beats on revenue https://seekingalpha.com/news/3464377-turquiose-hill-resources-beats-0_03-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3464377-turquiose-hill-resources-beats-0_03-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464340\" data-ts=\"1557953676\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XBIO\" target=\"_blank\">XBIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464340-xenetic-bio-down-27-on-planned-equity-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Xenetic Bio down 27% on planned equity offering</a></h4><ul><li>Thinly traded nano cap Xenetic Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/XBIO' title='Xenetic Biosciences, Inc.'>XBIO</a>) is down <font color=\"red\">27%</font> after hours on the heels of its <a href=\"https://www.sec.gov/Archives/edgar/data/1534525/000168316819001583/xenetic_s1.htm\" target=\"_blank\">preliminary prospectus</a> for a $17.5M stock offering.</li></ul><div class=\"tiny-share-widget\" data-id=\"3464340\" data-linked=\"Xenetic Bio down 27% on planned equity offering\" data-tweet=\"$XBIO - Xenetic Bio down 27% on planned equity offering https://seekingalpha.com/news/3464340-xenetic-bio-down-27-on-planned-equity-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3464340-xenetic-bio-down-27-on-planned-equity-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464339\" data-ts=\"1557953566\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADMA\" target=\"_blank\">ADMA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464339-adma-bio-down-10-after-hours-on-equity-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ADMA Bio down 10% after hours on equity offering</a></h4><ul><li>ADMA Biologics (NASDAQ:<a href='https://seekingalpha.com/symbol/ADMA' title='ADMA Biologics, Inc.'>ADMA</a>) slips <font color=\"red\">10%</font> after hours in response to its <a href=\"https://seekingalpha.com/pr/17514253-adma-biologics-announces-proposed-45-million-public-offering-common-stock\" target=\"_blank\">planned $45M stock offering</a>. Price, volume and terms have yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3464339\" data-linked=\"ADMA Bio down 10% after hours on equity offering\" data-tweet=\"$ADMA - ADMA Bio down 10% after hours on equity offering https://seekingalpha.com/news/3464339-adma-bio-down-10-after-hours-on-equity-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3464339-adma-bio-down-10-after-hours-on-equity-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:52 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464335\" data-ts=\"1557953240\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACHV\" target=\"_blank\">ACHV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464335-data-readout-on-achieves-cytisinicline-expected-next-month-shares-down-3-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Data readout on Achieve&#39;s cytisinicline expected next month; shares down 3% after hours</a></h4><ul><li>In its <a href=\"https://seekingalpha.com/pr/17514101-achieve-reports-financial-results-first-quarter-2019-provides-cytisinicline-clinical\" target=\"_blank\">Q1 report</a>, Achieve Life Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/ACHV' title='Achieve Life Sciences, Inc.'>ACHV</a>) announces that topline results from the Phase 2b <a href=\"https://clinicaltrials.gov/ct2/show/NCT03709823?lead=achieve+life+sciences&amp;phase=1&amp;rank=1\" target=\"_blank\">ORCA-1</a> trial evaluating smoking cessation med cytisinicline should be available by the end of next month. The last study visit by the last enrollee has taken place.</li><li>Investors are eager for the data, a classic biopharma binary event. Positive results should stoke heavy buying while negative results will undoubtedly produce a nice clean fall off a cliff.</li><li>Shares are down <font color=\"red\">3%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3464335\" data-linked=\"Data readout on Achieve&#39;s cytisinicline expected next month; shares down 3% after hours\" data-tweet=\"$ACHV - Data readout on Achieve&#39;s cytisinicline expected next month; shares down 3% after hours https://seekingalpha.com/news/3464335-data-readout-on-achieves-cytisinicline-expected-next-month-shares-down-3-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3464335-data-readout-on-achieves-cytisinicline-expected-next-month-shares-down-3-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:47 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464311\" data-ts=\"1557952575\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SORL\" target=\"_blank\">SORL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464311-sorl-auto-beats-0_19-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SORL Auto beats by $0.19, beats on revenue</a></h4><ul><li>SORL Auto (NASDAQ:<a href='https://seekingalpha.com/symbol/SORL' title='SORL Auto Parts, Inc.'>SORL</a>): Q1 GAAP EPS of $0.46 <font color=\"green\">beats by $0.19</font>.</li><li>Revenue of $136.22M (+26.4% Y/Y) <font color=\"green\">beats by $18.53M</font>.</li><li>Shares <font color=\"green\">+7.69%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17514233-sorl-auto-parts-reports-26_5-percent-net-sales-increase-first-quarter-2019\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3464311\" data-linked=\"SORL Auto beats by $0.19, beats on revenue\" data-tweet=\"$SORL - SORL Auto beats by $0.19, beats on revenue https://seekingalpha.com/news/3464311-sorl-auto-beats-0_19-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3464311-sorl-auto-beats-0_19-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464304\" data-ts=\"1557952375\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EYES\" target=\"_blank\">EYES</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464304-second-sight-up-14-on-q1-report-orion-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Second Sight up 14% on Q1 report, Orion outlook</a></h4><ul><li>Second Sight Medical (NASDAQ:<a href='https://seekingalpha.com/symbol/EYES' title='Second Sight Medical Products, Inc.'>EYES</a>) <a href=\"https://seekingalpha.com/pr/17514081-second-sight-reports-first-quarter-2019-financial-results\" target=\"_blank\">Q1 highlights</a>:</li><li>Net sales: $1.1M (+15.6%); net loss: ($9.7M); loss/share: ($0.10).</li><li>Production will suspended on new Argus II implants, commercial spending to be cut. Implantations to continue with existing inventory.</li><li>Resources expanded to support Orion Visual Prosthesis. U.S. reimbursement outlook positive under FDA's Breakthrough Devices designation.</li><li>Shares are up <font color=\"green\">14%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3464304\" data-linked=\"Second Sight up 14% on Q1 report, Orion outlook\" data-tweet=\"$EYES - Second Sight up 14% on Q1 report, Orion outlook https://seekingalpha.com/news/3464304-second-sight-up-14-on-q1-report-orion-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3464304-second-sight-up-14-on-q1-report-orion-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464269\" data-ts=\"1557951700\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FTCH\" target=\"_blank\">FTCH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464269-farfetchminus-5-after-losses-pile-higher\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Farfetch -5% after losses pile higher</a></h4><ul> <li>Farfetch (NYSE:<a href='https://seekingalpha.com/symbol/FTCH' title='Farfetch'>FTCH</a>) <font color=\"red\">falls 4.86%</font> in AH trading after the online retailer fell short of profit expectations with EPS of -$0.22 and adjusted EBITDA of -$30.2M.</li> <li>Active customers were up 64% Y/Y during the quarter to 1.69M and platform GMV rose 44%. </li><li>Previously: <a href=\"https://seekingalpha.com/news/3464224-farfetch-reports-q1-results\" target=\"_blank\">Farfetch reports Q1 results</a> (May 15)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3464269\" data-linked=\"Farfetch -5% after losses pile higher\" data-tweet=\"$FTCH - Farfetch -5% after losses pile higher https://seekingalpha.com/news/3464269-farfetchminus-5-after-losses-pile-higher?source=tweet\" data-url=\"https://seekingalpha.com/news/3464269-farfetchminus-5-after-losses-pile-higher\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:21 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464266\" data-ts=\"1557951678\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SINO\" target=\"_blank\">SINO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464266-sino-global-shipping-america-misses-0_08-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sino-Global Shipping America misses by $0.08, beats on revenue</a></h4><ul><li>Sino-Global Shipping America (NASDAQ:<a href='https://seekingalpha.com/symbol/SINO' title='Sino-Global Shipping America, Ltd.'>SINO</a>): Q3 GAAP EPS of -$0.09 <font color=\"red\">misses by $0.08</font>.</li><li>Revenue of $22.77M (+337.9% Y/Y) <font color=\"green\">beats by $16.65M</font>.</li><li>Shares <font color=\"green\">+19.06%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17514115-sino-global-announces-fiscal-2019-third-quarter-financial-results-highlighted-337_9-percent\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3464266\" data-linked=\"Sino-Global Shipping America misses by $0.08, beats on revenue\" data-tweet=\"$SINO - Sino-Global Shipping America misses by $0.08, beats on revenue https://seekingalpha.com/news/3464266-sino-global-shipping-america-misses-0_08-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3464266-sino-global-shipping-america-misses-0_08-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464264\" data-ts=\"1557951595\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABR\" target=\"_blank\">ABR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464264-arbor-realty-to-sell-8m-shares-and-buy-back-800k-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arbor Realty to sell 8M shares and buy back 800K shares</a></h4><ul><li>Arbor Realty Trust (NYSE:<a href='https://seekingalpha.com/symbol/ABR' title='Arbor Realty Trust, Inc.'>ABR</a>) <font color=\"red\">slips 1.5%</font> in after-hours trading after announcing <a href=\"https://seekingalpha.com/pr/17514130-arbor-realty-trust-inc-announces-public-offering-common-stock\" target=\"_blank\">plans for a public offering </a>of 8M shares of its common stock.</li><li>Intends to grant greenshoe option for up to an additional 1.2M shares.</li><li>Plans to use some of the net proceeds to buy 800,000 shares of its  stock from its CEO, Arbor Commercial Mortgage LLC, and an estate family  vehicle established by Arbor's CEO.</li><li>Also plans to use net proceeds for investments relating to its business and for general corporate purposes.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3462552-arbor-realty-q1-adjusted-ffo-rises-66-percent\" target=\"_blank\">Arbor Realty Q1 adjusted FFO rises 66%</a> (May. 10 2019)</li></ul><div class=\"tiny-share-widget\" data-id=\"3464264\" data-linked=\"Arbor Realty to sell 8M shares and buy back 800K shares\" data-tweet=\"$ABR - Arbor Realty to sell 8M shares and buy back 800K shares https://seekingalpha.com/news/3464264-arbor-realty-to-sell-8m-shares-and-buy-back-800k-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3464264-arbor-realty-to-sell-8m-shares-and-buy-back-800k-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464256\" data-ts=\"1557951447\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CSCO\" target=\"_blank\">CSCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464256-ciscoplus-2_5-amid-broad-product-sales-growth-in-q3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cisco +2.5% amid broad product sales growth in Q3</a></h4><ul>   <li>Cisco Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/CSCO' title='Cisco Systems, Inc.'>CSCO</a>) is <font color=\"green\">up 2.5%</font> postmarket after its fiscal Q3 results beat expectations with broad product revenue growth and double-digit gains in operating income.</li>    <li>Revenue overall grew 6%, as products grew 7% and services grew 3%.</li>    <li>Total gross margin was 64.6% on a non-GAAP basis (up from 64.5%), with product gross margin up to 62% from 61%, and service gross margin up to 66.3% from 65.8%.</li>    <li>Operating expenses grew just 1%. Operating income rose 12% as reported, and increased 6% non-GAAP, to $4.2B.</li>    <li>Net income grew 8% to $3.5B.</li>    <li>Revenue by product group (excluding divested Service Provider Video Software Solutions): Infrastructure Platforms, $7.5B (up 5%); Applications, $1.43B (up 9%); Security, $707M (up 21%); Other products, $39M (up 3%).</li>    <li>Cash flow from operations was $4.3B, up 79% (including $1.3B in one-time foreign taxes; normalized for those payments, it grew 16%).</li>    <li>For Q4, it's guiding to 4.5%-6.5% growth in revenues, which would result in $13.43B-$13.69B, above consensus for $13.29B.</li>    <li>It also forecasts non-GAAP gross margin of 64-65%; operating margin of 31-32%; and EPS of $0.80-$0.82, in line with consensus for $0.81.</li>    <li><a href=\"https://investor.cisco.com/\" target=\"_blank\">Conference call</a> to come at 4:30 p.m. ET.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3464216-cisco-beats-0_01-beats-revenue\" target=\"_blank\">Cisco beats by $0.01, beats on revenue</a> (May. 15 2019)</li>    <li><a href=\"https://seekingalpha.com/pr/17514107-cisco-reports-third-quarter-earnings\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3464256\" data-linked=\"Cisco +2.5% amid broad product sales growth in Q3\" data-tweet=\"$CSCO - Cisco +2.5% amid broad product sales growth in Q3 https://seekingalpha.com/news/3464256-ciscoplus-2_5-amid-broad-product-sales-growth-in-q3?source=tweet\" data-url=\"https://seekingalpha.com/news/3464256-ciscoplus-2_5-amid-broad-product-sales-growth-in-q3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>29&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464235\" data-ts=\"1557951174\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EYES\" target=\"_blank\">EYES</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464235-second-sight-misses-0_01-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Second Sight misses by $0.01, misses on revenue</a></h4><ul><li>Second Sight (NASDAQ:<a href='https://seekingalpha.com/symbol/EYES' title='Second Sight Medical Products, Inc.'>EYES</a>): Q1 Non-GAAP EPS of -$0.07 <font color=\"red\">misses by $0.01</font>; GAAP EPS of -$0.10 <font color=\"red\">misses by $0.03</font>.</li><li>Revenue of $1.13M (+15.3% Y/Y) <font color=\"red\">misses by $0.53M</font>.</li><li>Shares <font color=\"green\">+18.48%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17514081-second-sight-reports-first-quarter-2019-financial-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3464235\" data-linked=\"Second Sight misses by $0.01, misses on revenue\" data-tweet=\"$EYES - Second Sight misses by $0.01, misses on revenue https://seekingalpha.com/news/3464235-second-sight-misses-0_01-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3464235-second-sight-misses-0_01-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:12 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464233\" data-ts=\"1557951160\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AGIO\" target=\"_blank\">AGIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464233-agios-ivosidenib-successful-in-late-stage-cholangiocarcinoma-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Agios&#39; ivosidenib successful in late-stage cholangiocarcinoma study</a></h4><ul><li>A Phase 3 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT02989857?lead=agios&amp;phase=2&amp;rank=5\" target=\"_blank\">ClarIDHy</a>, evaluating Agios Pharmaceuticals' (NASDAQ:<a href='https://seekingalpha.com/symbol/AGIO' title='Agios Pharmaceuticals, Inc.'>AGIO</a>) TIBSOVO (ivosidenib) in previously treated patients with IDH1 mutation-positive cholangiocarcinoma <a href=\"https://seekingalpha.com/pr/17514052-agios-announces-randomized-phase-3-claridhy-trial-tibsovo-ivosidenib-achieved-primary\" target=\"_blank\">met the primary endpoint</a> of progression-free survival &#40;PFS&#41; compared to placebo.</li><li>Complete data will be submitted for presentation at ESMO in Barcelona in late September.</li><li>The IDH1 inhibitor is currently approved in the U.S. for IDH1-positive acute myeloid leukemia.</li></ul><div class=\"tiny-share-widget\" data-id=\"3464233\" data-linked=\"Agios&#39; ivosidenib successful in late-stage cholangiocarcinoma study\" data-tweet=\"$AGIO - Agios&#39; ivosidenib successful in late-stage cholangiocarcinoma study https://seekingalpha.com/news/3464233-agios-ivosidenib-successful-in-late-stage-cholangiocarcinoma-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3464233-agios-ivosidenib-successful-in-late-stage-cholangiocarcinoma-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:12 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464216\" data-ts=\"1557950786\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CSCO\" target=\"_blank\">CSCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464216-cisco-beats-0_01-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cisco beats by $0.01, beats on revenue</a></h4><ul><li>Cisco (NASDAQ:<a href='https://seekingalpha.com/symbol/CSCO' title='Cisco Systems, Inc.'>CSCO</a>): Q3 Non-GAAP EPS of $0.78 <font color=\"green\">beats by $0.01</font>; GAAP EPS of $0.69 <font color=\"green\">beats by $0.03</font>.</li><li>Revenue of $12.96B (+4.0% Y/Y) <font color=\"green\">beats by $70M</font>.</li><li>Shares <font color=\"green\">+1.3%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17514107-cisco-reports-third-quarter-earnings\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3464216\" data-linked=\"Cisco beats by $0.01, beats on revenue\" data-tweet=\"$CSCO - Cisco beats by $0.01, beats on revenue https://seekingalpha.com/news/3464216-cisco-beats-0_01-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3464216-cisco-beats-0_01-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>30&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464200\" data-ts=\"1557950078\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UNIT\" target=\"_blank\">UNIT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464200-uniti-falls-after-windstream-mentions-high-lease-costs\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Uniti falls after Windstream mentions high lease costs</a></h4><ul><li>Uniti (NASDAQ:<a href='https://seekingalpha.com/symbol/UNIT' title='Uniti Group Inc.'>UNIT</a>) <font color=\"red\">-5.7%</font> after Windstream (<a href='https://seekingalpha.com/symbol/WINMQ' title='Windstream Holdings, Inc.'>OTCPK:WINMQ</a>) says in its Q1 earnings release it is <a href=\"https://seekingalpha.com/pr/17513126-windstream-reports-first-quarter-2019-results\" target=\"_blank\">evaluating all options</a> on its lease agreement with Uniti, including \u201crenegotiation, recharacterization and rejection of the agreement.\u201d</li><li>\u201cWe believe the lease payment under the master lease is significantly above market. In fact, given the prescriptive valuation process outlined in the lease, we estimate payment could be reduced by 80% or more if the lease were to be renewed in 2030 because of the significant decline in the value of copper facilities, which comprised 54% of the initial value of the lease in 2015,\u201d Windstream CEO Tony Thomas said.</li></ul><div class=\"tiny-share-widget\" data-id=\"3464200\" data-linked=\"Uniti falls after Windstream mentions high lease costs\" data-tweet=\"$UNIT $UNIT $WINMQ - Uniti falls after Windstream mentions high lease costs https://seekingalpha.com/news/3464200-uniti-falls-after-windstream-mentions-high-lease-costs?source=tweet\" data-url=\"https://seekingalpha.com/news/3464200-uniti-falls-after-windstream-mentions-high-lease-costs\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>377&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464198\" data-ts=\"1557949855\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GSKY\" target=\"_blank\">GSKY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464198-greenskyminus-10_4-on-impending-funding-loss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GreenSky -10.4% on impending funding loss</a></h4><ul><li>GreenSky (NASDAQ:<a href='https://seekingalpha.com/symbol/GSKY' title='GreenSky, Inc.'>GSKY</a>)<font color=\"red\"> plunges 10.4%</font> after this morning's <a href=\"https://seekingalpha.com/filing/4490490\" target=\"_blank\">reveal</a> that Regions Financial won\u2019t renew an indirect funding commitment that expires in Q4.</li><li>SunTrust doesn't think the change limits GreenSky's FY19 revenue outlook but notes that Regions accounts for about 17% of GSKY's total maximum funding commitment.</li></ul><div class=\"tiny-share-widget\" data-id=\"3464198\" data-linked=\"GreenSky -10.4% on impending funding loss\" data-tweet=\"$GSKY - GreenSky -10.4% on impending funding loss https://seekingalpha.com/news/3464198-greenskyminus-10_4-on-impending-funding-loss?source=tweet\" data-url=\"https://seekingalpha.com/news/3464198-greenskyminus-10_4-on-impending-funding-loss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:50 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464194\" data-ts=\"1557948802\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PFSCF\" target=\"_blank\">PFSCF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464194-prometic-sets-terms-for-rights-offering-shares-down-11\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Prometic sets terms for rights offering; shares down 11%</a></h4><ul><li>Prometic Life Sciences (<a href='https://seekingalpha.com/symbol/PFSCF' title='Prometic Life Sciences Inc.'>OTCQX:PFSCF</a> <font color=\"red\">-10.9%</font>) has <a href=\"https://seekingalpha.com/pr/17514004-prometic-announces-terms-equity-rights-offering\" target=\"_blank\">confirmed the terms</a> of its $75 equity rights offering for Canadian investors.</li><li>Stockholders of record on May 21 will have one right per share owned to subscribe for up to 20 common shares at $0.01521 per share.</li><li>Proceeds will fund operations.</li></ul><div class=\"tiny-share-widget\" data-id=\"3464194\" data-linked=\"Prometic sets terms for rights offering; shares down 11%\" data-tweet=\"$PFSCF - Prometic sets terms for rights offering; shares down 11% https://seekingalpha.com/news/3464194-prometic-sets-terms-for-rights-offering-shares-down-11?source=tweet\" data-url=\"https://seekingalpha.com/news/3464194-prometic-sets-terms-for-rights-offering-shares-down-11\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:33 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464187\" data-ts=\"1557947422\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WLK\" target=\"_blank\">WLK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464187-westlake-to-benefit-ethylene-chloralkali-cycles-bottom-goldman-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Westlake to benefit as ethylene, chloralkali cycles bottom, Goldman says</a></h4><ul><li>Westlake Chemical (<a href='https://seekingalpha.com/symbol/WLK' title='Westlake Chemical Corporation'>WLK</a> <font color='green'>+2.4%</font>) is <a href=\"https://thefly.com/thestreet/realmoney/index.php/WLKid2909548/WLK-Goldman-upgrades-Westlake-Chemical-to-Buy-after--oneyear-selloff-\" target=\"_blank\">upgraded to Buy</a> from Neutral with an $84 price target, lifted from $81, at Goldman Sachs, which says the stock's nearly 50% decline over the past year has created an opportunity to gain exposure to two commodity cycles that are bottoming, ethylene and chloralkali.</li><li>Goldman's Robert Koort expects WLK will enjoy margin growth and valuation improvement as investors gain comfort with the establishment of an ethylene \"super trough\" in H2 2019.</li><li>WLK has even greater exposure to the chloralkali \"cyclical rewind\" as the fall of caustic soda prices approaches a bottom again, Koort says.</li></ul><div class=\"tiny-share-widget\" data-id=\"3464187\" data-linked=\"Westlake to benefit as ethylene, chloralkali cycles bottom, Goldman says\" data-tweet=\"$WLK - Westlake to benefit as ethylene, chloralkali cycles bottom, Goldman says https://seekingalpha.com/news/3464187-westlake-to-benefit-ethylene-chloralkali-cycles-bottom-goldman-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3464187-westlake-to-benefit-ethylene-chloralkali-cycles-bottom-goldman-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:10 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464183\" data-ts=\"1557946329\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OSTK\" target=\"_blank\">OSTK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464183-multi-year-low-for-overstock-com-after-ceo-sells-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Multi-year low for Overstock.com after CEO sells shares</a></h4><ul> <li>Overstock.com (<a href='https://seekingalpha.com/symbol/OSTK' title='Overstock.com, Inc.'>OSTK</a> <font color='red'>-15.1%</font>) falls sharply on more insider sales by CEO Patrick Byrne.</li> <li>Byrne sold 500K shares this week split between a sale of 250K shares at $13.33 on May 13 and 250K shares at $12.84 on May 14.</li><li>Shares of OSTK dropped to a multi-year low of $10.65 earlier this afternoon.</li> <li><a href=\"https://seekingalpha.com/filing/4491052\" target=\"_blank\">SEC Form 4</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3464183\" data-linked=\"Multi-year low for Overstock.com after CEO sells shares\" data-tweet=\"$OSTK - Multi-year low for Overstock.com after CEO sells shares https://seekingalpha.com/news/3464183-multi-year-low-for-overstock-com-after-ceo-sells-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3464183-multi-year-low-for-overstock-com-after-ceo-sells-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:52 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464179\" data-ts=\"1557945744\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOOG\" target=\"_blank\">GOOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464179-google-recalls-keys-for-security-issue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Google recalls Keys for security issue</a></h4><ul><li>Google (<a href='https://seekingalpha.com/symbol/GOOG' title='Alphabet Inc.'>GOOG</a> <font color='green'>+4.1%</font>)(<a href='https://seekingalpha.com/symbol/GOOGL' title='Alphabet Inc.'>GOOGL</a> <font color='green'>+4.3%</font>) <a href=\"https://www.cnbc.com/2019/05/15/google-finds-security-issue-with-its-bluetooth-titan-security-keys.html\" target=\"_blank\">recalls</a> its Bluetooth Titan Security Keys after finding a flaw that let anyone within 30 feet access the key and its paired device while the owner was working to activate the key or pair the two.</li><li>Google says the issue doesn't interfere with the key's ability to protect users from a remote attack.</li><li>Bluetooth Titan owners can get a free replacement from the company.</li></ul><div class=\"tiny-share-widget\" data-id=\"3464179\" data-linked=\"Google recalls Keys for security issue\" data-tweet=\"$GOOG $GOOGL - Google recalls Keys for security issue https://seekingalpha.com/news/3464179-google-recalls-keys-for-security-issue?source=tweet\" data-url=\"https://seekingalpha.com/news/3464179-google-recalls-keys-for-security-issue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464162\" data-ts=\"1557944171\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464162-nasdaq-leads-stocks-continue-to-rebound\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nasdaq leads as stocks continue to rebound</a></h4><ul><li>Google is <font color=\"green\">up more than 4%</font> and Facebook <font color=\"green\">more than 3%</font>, helping the Nasdaq to a <font color=\"green\">1.25% advance</font> less than two hours before the close.</li><li>The S&amp;P 500 is <font color=\"green\">up 0.8% </font>and the Dow <font color=\"green\">0.65%</font>.</li><li>Markets were goosed earlier this morning on a report the White House will delay implementation of auto tariffs against the EU.</li><li>The 10-year Treasury yield is off three basis points, helped along by a <a href=\"https://seekingalpha.com/news/3463951-april-core-retail-sales-disappoint\" target=\"_blank\">soft retail sales report</a> for April.</li></ul><div class=\"tiny-share-widget\" data-id=\"3464162\" data-linked=\"Nasdaq leads as stocks continue to rebound\" data-tweet=\"Nasdaq leads as stocks continue to rebound https://seekingalpha.com/news/3464162-nasdaq-leads-stocks-continue-to-rebound?source=tweet\" data-url=\"https://seekingalpha.com/news/3464162-nasdaq-leads-stocks-continue-to-rebound\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464160\" data-ts=\"1557944045\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSTI\" target=\"_blank\">SSTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464160-shotspotterplus-1_8-imperial-turns-bullish\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ShotSpotter +1.8% as Imperial turns bullish</a></h4><ul><li>Imperial Capital upgrades ShotSpotter (NASDAQ:<a href='https://seekingalpha.com/symbol/SSTI' title='ShotSpotter, Inc.'>SSTI</a>) from In-Line to Outperform with a $49 price target.</li><li>The firm cites the pullback following the <a href=\"https://seekingalpha.com/news/3462075-shotspotter-misses-0_01-misses-revenue\" target=\"_blank\">Q1 print</a>, confidence in SSTI's growth and profitability outlook, and a recent software acquisition that could provide better margins than the core business.</li><li>Imperial says SSTI's dominant market position could make it an attractive M&amp;A candidate.</li><li>SSTI shares are <font color=\"green\">up 1.8%</font> to $45.13.</li></ul><div class=\"tiny-share-widget\" data-id=\"3464160\" data-linked=\"ShotSpotter +1.8% as Imperial turns bullish\" data-tweet=\"$SSTI - ShotSpotter +1.8% as Imperial turns bullish https://seekingalpha.com/news/3464160-shotspotterplus-1_8-imperial-turns-bullish?source=tweet\" data-url=\"https://seekingalpha.com/news/3464160-shotspotterplus-1_8-imperial-turns-bullish\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464158\" data-ts=\"1557943840\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROAN\" target=\"_blank\">ROAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464158-roan-resourcesminus-17-after-cutting-2019-production-forecast\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Roan Resources -17% after cutting 2019 production forecast</a></h4><ul><li>Roan Resources (<a href='https://seekingalpha.com/symbol/ROAN' title='Roan Resources, Inc.'>ROAN</a> <font color='red'>-17.7%</font>) surrenders nearly all of its gains from the past two weeks after <a href=\"https://seekingalpha.com/news/3463784-roan-resources-misses-q1-boosted-boe-production-30-percent\" target=\"_blank\">lowering its full-year production guidance</a> by ~7% to 51.5K-55.5K boe/day from 56K-59K previously.</li><li>Chairman Joseph Mills said in a conference call that he is focused on bringing  back capital discipline by cutting drilling, operating and G&amp;A  costs, and plans to \"determine the best strategic path forward.\"</li><li>\"We remain focused and still forecast to be cash flow positive\" in Q4, Mills said, but the decision to increase number of rigs to eight last year was \"far too aggressive\"; the number dropped to four by the end of January.</li><li>Mills says Roan is in the final stages of engaging one or more investment  banks to help evaluate strategic opportunities that include a potential sale of  the company, but \"consolidation at least for me personally makes a lot more sense.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3464158\" data-linked=\"Roan Resources -17% after cutting 2019 production forecast\" data-tweet=\"$ROAN - Roan Resources -17% after cutting 2019 production forecast https://seekingalpha.com/news/3464158-roan-resourcesminus-17-after-cutting-2019-production-forecast?source=tweet\" data-url=\"https://seekingalpha.com/news/3464158-roan-resourcesminus-17-after-cutting-2019-production-forecast\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:10 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464156\" data-ts=\"1557943459\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VMW\" target=\"_blank\">VMW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464156-vmware-acquires-app-packing-solutions-provider\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">VMware acquires app-packing solutions provider</a></h4><ul><li>VMware (NYSE:<a href='https://seekingalpha.com/symbol/VMW' title='VMware, Inc.'>VMW</a>) <a href=\"https://cloud.vmware.com/community/2019/05/15/vmware-to-acquire-bitnami/\" target=\"_blank\">acquires</a> Bitnami for an undisclosed amount.</li><li>Bitnami can deliver more than 130 popular software packages in a variety of forms, which will help VMware with its cloud services push.</li><li>VMware shares are <font color=\"green\">up 1.8%</font> to $201.50.</li></ul><div class=\"tiny-share-widget\" data-id=\"3464156\" data-linked=\"VMware acquires app-packing solutions provider\" data-tweet=\"$VMW - VMware acquires app-packing solutions provider https://seekingalpha.com/news/3464156-vmware-acquires-app-packing-solutions-provider?source=tweet\" data-url=\"https://seekingalpha.com/news/3464156-vmware-acquires-app-packing-solutions-provider\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:04 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464149\" data-ts=\"1557943142\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464149-silvercrest-metals-and-new-concept-energy-among-energy-materials-gainers-roan-resources-and\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SilverCrest Metals and New Concept Energy among Energy/Materials gainers; Roan Resources and SAExploration among losers</a></h4><ul><li><b>Gainers: </b>SilverCrest Metals (NYSEMKT:<a href='https://seekingalpha.com/symbol/SILV' title='SilverCrest Metals Inc.'>SILV</a>) <font color=\"green\">+7%</font>. New Concept Energy (NYSEMKT:<a href='https://seekingalpha.com/symbol/GBR' title='New Concept Energy, Inc.'>GBR</a>) <font color=\"green\">+7%</font>. Oil-Dri Corporation of America (NYSE:<a href='https://seekingalpha.com/symbol/ODC' title='Oil-Dri Corporation of America'>ODC</a>) <font color=\"green\">+7%</font>. Eldorado Gold (NYSE:<a href='https://seekingalpha.com/symbol/EGO' title='Eldorado Gold Corporation'>EGO</a>) <font color=\"green\">+7%</font>. NextDecade (NASDAQ:<a href='https://seekingalpha.com/symbol/NEXT' title='NextDecade Corporation'>NEXT</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers: </b>Roan Resources (NYSE:<a href='https://seekingalpha.com/symbol/ROAN' title='Roan Resources, Inc.'>ROAN</a>) <font color=\"red\">-20%</font>. SAExploration (NASDAQ:<a href='https://seekingalpha.com/symbol/SAEX' title='SAExploration Holdings, Inc.'>SAEX</a>) <font color=\"red\">-11%</font>. Fortuna Silver Mines (NYSE:<a href='https://seekingalpha.com/symbol/FSM' title='Fortuna Silver Mines Inc.'>FSM</a>) <font color=\"red\">-9%</font>. Hi-Crush Partners (NYSE:<a href='https://seekingalpha.com/symbol/HCLP' title='Hi-Crush Partners LP'>HCLP</a>) <font color=\"red\">-8%</font>. CARBO Ceramics (NYSE:<a href='https://seekingalpha.com/symbol/CRR' title='CARBO Ceramics Inc.'>CRR</a>) <font color=\"red\">-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3464149\" data-linked=\"SilverCrest Metals and New Concept Energy among Energy/Materials gainers; Roan Resources and SAExploration among losers\" data-tweet=\"$SILV $GBR $ODC - SilverCrest Metals and New Concept Energy among Energy/Materials gainers; Roan Resources and SAExploration among losers https://seekingalpha.com/news/3464149-silvercrest-metals-and-new-concept-energy-among-energy-materials-gainers-roan-resources-and?source=tweet\" data-url=\"https://seekingalpha.com/news/3464149-silvercrest-metals-and-new-concept-energy-among-energy-materials-gainers-roan-resources-and\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464144\" data-ts=\"1557941906\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464144-epic-games-store-executes-quiet-launch-in-china\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Epic Games store executes quiet launch in China</a></h4><ul>   <li>Take-Two Interactive Software (NASDAQ:<a href='https://seekingalpha.com/symbol/TTWO' title='Take-Two Interactive Software, Inc.'>TTWO</a>) is <font color=\"green\">up 4.5%</font> following a relatively quiet <a href=\"https://www.pcgamesn.com/epic-games-store-china\" target=\"_blank\">launch of the Epic Games store</a> on the Chinese mainland.</li>    <li>A report in China's Techweb says that regional players can purchase and play games if they pay through WeChat or AliPay (but not Chinese credit cards) -- and at substantially lower prices than in North America. The store could be keeping a low profile considering a strictly regulated game market.</li>    <li>That's a positive for publishers including Take-Two and Ubisoft (<a href=\"http://seekingalpha.com/symbol/UBSFY\" target=\"_blank\">UBSFY</a> <font color=\"red\">-4.8%</font>), Goldman Sachs says, with an eye to new and upcoming titles.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3464144\" data-linked=\"Epic Games store executes quiet launch in China\" data-tweet=\"$TTWO $UBSFY $UBSFF - Epic Games store executes quiet launch in China https://seekingalpha.com/news/3464144-epic-games-store-executes-quiet-launch-in-china?source=tweet\" data-url=\"https://seekingalpha.com/news/3464144-epic-games-store-executes-quiet-launch-in-china\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464141\" data-ts=\"1557941688\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PANW\" target=\"_blank\">PANW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464141-palo-altominus-2_3-on-weak-mizuho-checks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Palo Alto -2.3% on weak Mizuho checks</a></h4><ul><li>Mizuho says recent Palo Alto Networks (NYSE:<a href='https://seekingalpha.com/symbol/PANW' title='Palo Alto Networks, Inc.'>PANW</a>) checks show \"more subdued levels of product demand.\"</li><li>The firm says significant revenue outperformance is unlikely this quarter and notes that PANW investors \"have become accustomed to healthy upside.\"</li><li>Rating stays at Buy, but the PT drops from $285 to $265.</li><li>Palo Alto reports earnings on May 29, and <a href=\"https://seekingalpha.com/symbol/PANW/earnings\" target=\"_blank\">consensus estimates</a> expect $705.02M in revenue with $1.25 EPS.</li><li>PANW shares are <font color=\"red\">down 2.3%</font> to $221.50.</li></ul><div class=\"tiny-share-widget\" data-id=\"3464141\" data-linked=\"Palo Alto -2.3% on weak Mizuho checks\" data-tweet=\"$PANW - Palo Alto -2.3% on weak Mizuho checks https://seekingalpha.com/news/3464141-palo-altominus-2_3-on-weak-mizuho-checks?source=tweet\" data-url=\"https://seekingalpha.com/news/3464141-palo-altominus-2_3-on-weak-mizuho-checks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:34 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464139\" data-ts=\"1557941559\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NRIFF\" target=\"_blank\">NRIFF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464139-horizon-on-short-end-of-appeal-of-vimovo-patents\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Horizon on short end of appeal of Vimovo patents</a></h4><ul><li>The U.S. Court of Appeals for the Federal Circuit has <a href=\"https://seekingalpha.com/pr/17513877-nuvo-pharmaceuticals-announces-u-s-court-appeals-federal-circuit-reverses-district-courts\" target=\"_blank\">reversed </a>a lower court decision over the alleged infringement by generic competitors of two U.S. patents covering Horizon Therapeutics' (<a href='https://seekingalpha.com/symbol/HZNP' title='Horizon Therapeutics Public Limited Company'>HZNP</a> <font color=\"red\">-1%</font>) Vimovo (naproxen/esomeprazole magnesium).</li><li>In June 2017, a New Jersey district court <a href=\"https://seekingalpha.com/news/3275659-aralez-pharma-prevails-vimovo-patent-challenge\" target=\"_blank\">upheld the validity</a> of the patents (Nos. 6,926,907 and 8,557,285).</li><li>Horizon acquired the U.S. rights to the drug from AstraZeneca (<a href='https://seekingalpha.com/symbol/AZN' title='AstraZeneca PLC'>AZN</a> <font color=\"red\">-0.2%</font>) in November 2013. Canadian outfit Nuvo Pharmaceuticals (<a href='https://seekingalpha.com/symbol/NRIFF' title='Nuvo Pharmaceuticals Inc.'>OTCQX:NRIFF</a>) supplies the product to Horizon under an eight-year contract.</li></ul><div class=\"tiny-share-widget\" data-id=\"3464139\" data-linked=\"Horizon on short end of appeal of Vimovo patents\" data-tweet=\"$NRIFF $HZNP $AZN - Horizon on short end of appeal of Vimovo patents https://seekingalpha.com/news/3464139-horizon-on-short-end-of-appeal-of-vimovo-patents?source=tweet\" data-url=\"https://seekingalpha.com/news/3464139-horizon-on-short-end-of-appeal-of-vimovo-patents\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:32 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464137\" data-ts=\"1557940102\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464137-x-financial-leads-financial-gainers-senmiao-technology-and-rand-capital-only-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">X Financial leads financial gainers; Senmiao Technology and Rand Capital the only losers</a></h4><ul><li><b>Gainers:</b> X Financial (NYSE:<a href='https://seekingalpha.com/symbol/XYF' title='X Financial'>XYF</a>) <font color=\"green\">+9%</font>. 1347 Property Insurance Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/PIH' title='1347 Property Insurance Holdings, Inc.'>PIH</a>) <font color=\"green\">+7%</font>. eHealth (NASDAQ:<a href='https://seekingalpha.com/symbol/EHTH' title='eHealth, Inc.'>EHTH</a>) <font color=\"green\">+7%</font>. Futu Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/FHL' title='Futu Holdings Limited'>FHL</a>) <font color=\"green\">+6%</font>. Kingstone Companies (NASDAQ:<a href='https://seekingalpha.com/symbol/KINS' title='Kingstone Companies, Inc.'>KINS</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers:</b> Senmiao Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/AIHS' title='Senmiao Technology Limited'>AIHS</a>) <font color=\"red\">-7%</font>. Rand Capital (NASDAQ:<a href='https://seekingalpha.com/symbol/RAND' title='Rand Capital'>RAND</a>) <font color=\"red\">-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3464137\" data-linked=\"X Financial leads financial gainers; Senmiao Technology and Rand Capital the only losers\" data-tweet=\"$XYF $PIH $EHTH - X Financial leads financial gainers; Senmiao Technology and Rand Capital the only losers https://seekingalpha.com/news/3464137-x-financial-leads-financial-gainers-senmiao-technology-and-rand-capital-only-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3464137-x-financial-leads-financial-gainers-senmiao-technology-and-rand-capital-only-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464136\" data-ts=\"1557939964\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLPS\" target=\"_blank\">CLPS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464136-cpsplus-4_3-invests-in-financial-big-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CPS +4.3% as it invests in financial big data</a></h4><ul><li>CLPS (NASDAQ:<a href='https://seekingalpha.com/symbol/CLPS' title='CLPS Incorporation'>CLPS</a>) <font color=\"green\">gains 4.3% </font>after <a href=\"https://seekingalpha.com/pr/17512846-clps-incorporation-announces-strategic-investment-emit-financial-big-data-company\" target=\"_blank\">agreeing </a>to take a 30% stake in Economic Modeling Information Technology, a financial big data company.</li><li>\"EMIT's expertise in data modeling, deep learning and machine learning, and blockchain technology will benefit CLPS's future development by further expanding our client network,\" said CLPS co-founder and CEO Raymond Lin. \"In addition, by offering applications of data mining, we will be able to extend our competitive edge in the banking, insurance and financial sectors.\"</li><li>Terms of the deal weren't disclosed.</li></ul><div class=\"tiny-share-widget\" data-id=\"3464136\" data-linked=\"CPS +4.3% as it invests in financial big data\" data-tweet=\"$CLPS - CPS +4.3% as it invests in financial big data https://seekingalpha.com/news/3464136-cpsplus-4_3-invests-in-financial-big-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3464136-cpsplus-4_3-invests-in-financial-big-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:06 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464133\" data-ts=\"1557939683\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464133-ballard-power-systems-and-hydrogenics-among-industrial-gainers-clearsign-combustion-and\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ballard Power Systems and Hydrogenics among industrial gainers; ClearSign Combustion and Lindsay among losers</a></h4><ul><li><b>Gainers: </b>Ampco-Pittsburgh (NYSE:<a href='https://seekingalpha.com/symbol/AP' title='Ampco-Pittsburgh Corporation'>AP</a>) <font color=\"green\">+10%</font>. Hydrogenics (NASDAQ:<a href='https://seekingalpha.com/symbol/HYGS' title='Hydrogenics Corporation'>HYGS</a>) <font color=\"green\">+9%</font>. Jewett-Cameron Trading Company (NASDAQ:<a href='https://seekingalpha.com/symbol/JCTCF' title='Jewett-Cameron Trading Company Ltd.'>JCTCF</a>) <font color=\"green\">+8%</font>. LiqTech International (NASDAQ:<a href='https://seekingalpha.com/symbol/LIQT' title='LiqTech International, Inc.'>LIQT</a>) <font color=\"green\">+6%</font>. Ballard Power Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/BLDP' title='Ballard Power Systems Inc.'>BLDP</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers: </b>Charah Solutions (NYSE:<a href='https://seekingalpha.com/symbol/CHRA' title='Charah Solutions, Inc.'>CHRA</a>) <font color=\"red\">-21%</font>. ClearSign Combustion (NASDAQ:<a href='https://seekingalpha.com/symbol/CLIR' title='ClearSign Combustion Corporation'>CLIR</a>) <font color=\"red\">-13%</font>. Lindsay (NYSE:<a href='https://seekingalpha.com/symbol/LNN' title='Lindsay Corporation'>LNN</a>) <font color=\"red\">-8%</font>. Aqua Metals (NASDAQ:<a href='https://seekingalpha.com/symbol/AQMS' title='Aqua Metals, Inc.'>AQMS</a>) <font color=\"red\">-6%</font>. Industrea Acquisition (NASDAQ:<a href='https://seekingalpha.com/symbol/BBCP' title='Industrea Acquisition Corp.'>BBCP</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3464133\" data-linked=\"Ballard Power Systems and Hydrogenics among industrial gainers; ClearSign Combustion and Lindsay among losers\" data-tweet=\"$AP $HYGS $JCTCF - Ballard Power Systems and Hydrogenics among industrial gainers; ClearSign Combustion and Lindsay among losers https://seekingalpha.com/news/3464133-ballard-power-systems-and-hydrogenics-among-industrial-gainers-clearsign-combustion-and?source=tweet\" data-url=\"https://seekingalpha.com/news/3464133-ballard-power-systems-and-hydrogenics-among-industrial-gainers-clearsign-combustion-and\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464126\" data-ts=\"1557938761\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CACI\" target=\"_blank\">CACI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464126-caci-secures-prime-position-on-982m-u-s-army-r4-multiple-award-contract\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CACI secures prime position on $982M U.S. Army R4 multiple-award contract</a></h4><ul><li>CACI International (<a href='https://seekingalpha.com/symbol/CACI' title='CACI International Inc'>CACI</a> <font color=\"green\">+1%</font>) has been <a href=\"https://seekingalpha.com/pr/17512890-caci-awarded-prime-position-982-million-u-s-army-r4-multiple-award-contract-provide\" target=\"_blank\">awarded</a> a prime position on the multiple-award, indefinite delivery/indefinite quantity U.S. Army R4 contract, with a ceiling value of $982M.</li><li>Through this contract vehicle, CACI will integrate high-end electronic warfare and cyber services, solutions, and products to support Army cyber operations.</li></ul><div class=\"tiny-share-widget\" data-id=\"3464126\" data-linked=\"CACI secures prime position on $982M U.S. Army R4 multiple-award contract\" data-tweet=\"$CACI - CACI secures prime position on $982M U.S. Army R4 multiple-award contract https://seekingalpha.com/news/3464126-caci-secures-prime-position-on-982m-u-s-army-r4-multiple-award-contract?source=tweet\" data-url=\"https://seekingalpha.com/news/3464126-caci-secures-prime-position-on-982m-u-s-army-r4-multiple-award-contract\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:46 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464127\" data-ts=\"1557938710\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464127-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul><li><strong>Gainers</strong>: PDS Biotechnology (NASDAQ:<a href='https://seekingalpha.com/symbol/PDSB' title='PDS Biotechnology Corporation'>PDSB</a>) <font color=\"green\">+35%</font>. Navios Maritime Holdings (NYSE:<a href='https://seekingalpha.com/symbol/NM' title='Navios Maritime Holdings Inc.'>NM</a>) <font color=\"green\">+26%</font>. Cellectar Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/CLRB' title='Cellectar Biosciences, Inc.'>CLRB</a>) <font color=\"green\">+21%</font>. Nordic American Tankers (NYSE:<a href='https://seekingalpha.com/symbol/NAT' title='Nordic American Tankers Limited'>NAT</a>) <font color=\"green\">+14%</font>. Ocean Bio-Chem (NASDAQ:<a href='https://seekingalpha.com/symbol/OBCI' title='Ocean Bio-Chem, Inc.'>OBCI</a>) <font color=\"green\">+13%</font>. Genetic Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/GENE' title='Genetic Technologies Limited'>GENE</a>) <font color=\"green\">+13%</font>. Amdocs (NASDAQ:<a href='https://seekingalpha.com/symbol/DOX' title='Amdocs Limited'>DOX</a>) <font color=\"green\">+13%</font>. Catalyst Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CPRX' title='Catalyst Pharmaceuticals, Inc.'>CPRX</a>) <font color=\"green\">+12%. </font>Precipio (NASDAQ:<a href='https://seekingalpha.com/symbol/PRPO' title='Precipio, Inc.'>PRPO</a>) <font color=\"green\">+11%</font>. Cumberland Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CPIX' title='Cumberland Pharmaceuticals Inc.'>CPIX</a>) <font color=\"green\">+12%</font>.</li> <li><strong>Losers</strong>: ImmunoGen (NASDAQ:<a href='https://seekingalpha.com/symbol/IMGN' title='ImmunoGen, Inc.'>IMGN</a>) <font color=\"red\">-34%</font>. electroCore (NASDAQ:<a href='https://seekingalpha.com/symbol/ECOR' title='electroCore, Inc.'>ECOR</a>) <font color=\"red\">-25%</font>. Charah Solutions (NYSE:<a href='https://seekingalpha.com/symbol/CHRA' title='Charah Solutions, Inc.'>CHRA</a>) <font color=\"red\">-22%</font>. Evofem Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/EVFM' title='Evofem Biosciences, Inc.'>EVFM</a>) <font color=\"red\">-20%</font>. Sunworks (NASDAQ:<a href='https://seekingalpha.com/symbol/SUNW' title='Sunworks, Inc.'>SUNW</a>) <font color=\"red\">-17%</font>. AeroCentury (NYSEMKT:<a href='https://seekingalpha.com/symbol/ACY' title='AeroCentury Corp.'>ACY</a>) <font color=\"red\">-17%</font>. Co-Diagnostics (NASDAQ:<a href='https://seekingalpha.com/symbol/CODX' title='Co-Diagnostics, Inc.'>CODX</a>) <font color=\"red\">-16%</font>. Westwater Resources (NASDAQ:<a href='https://seekingalpha.com/symbol/WWR' title='Westwater Resources, Inc.'>WWR</a>) <font color=\"red\">-15%</font>. Outlook Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/OTLK' title='Outlook Therapeutics, Inc.'>OTLK</a>) <font color=\"red\">-15%</font>. ENDRA Life Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/NDRA' title='ENDRA Life Sciences Inc.'>NDRA</a>) <font color=\"red\">-15%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3464127\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$PDSB $NM $CLRB - Midday Gainers / Losers https://seekingalpha.com/news/3464127-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3464127-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464125\" data-ts=\"1557938547\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TTD\" target=\"_blank\">TTD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464125-trade-deskplus-5-after-ceos-mad-money-appearance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">The Trade Desk +5% after CEO&#39;s &#39;Mad Money&#39; appearance</a></h4><ul>   <li>The Trade Desk (NASDAQ:<a href='https://seekingalpha.com/symbol/TTD' title='The Trade Desk, Inc.'>TTD</a>) is among top Nasdaq gainers today, <font color=\"green\">up 5%</font> after CEO Jeff Green made an <a href=\"https://www.cnbc.com/video/2019/05/14/trade-desk-ceo-we-bring-money-into-china-instead-of-bringing-it-out.html\" target=\"_blank\">appearance on Jim Cramer's <i>Mad Money.</i></a></li>    <li>One thing that differentiates the company from rivals (particularly in a trade-war environment) is its approach to China: \u201cInstead of trying to tap into the Chinese consumer and take money out, let\u2019s bring spend, or advertising spend, from the biggest brands in the world\" into the country, he says.</li>    <li>\u201cAnd it\u2019s made it easy for us to go into China when other people are running out, because we\u2019re using a different playbook.\u201d</li>    <li>Meanwhile, the company can partner with giant media companies like Google, Amazon, Facebook, Apple, Baidu, Alibaba and Tencent since \u201cwe don\u2019t own any media, so we\u2019re not competing with them.\"</li>    <li>The stock slipped following earnings last week despite a <a href=\"https://seekingalpha.com/news/3461734-trade-desk-minus-3_7-percent-despite-beat-raise\" target=\"_blank\">beat-and-raise</a> in its Q1 report.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3464125\" data-linked=\"The Trade Desk +5% after CEO&#39;s &#39;Mad Money&#39; appearance\" data-tweet=\"$TTD - The Trade Desk +5% after CEO&#39;s &#39;Mad Money&#39; appearance https://seekingalpha.com/news/3464125-trade-deskplus-5-after-ceos-mad-money-appearance?source=tweet\" data-url=\"https://seekingalpha.com/news/3464125-trade-deskplus-5-after-ceos-mad-money-appearance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>33&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464118\" data-ts=\"1557937572\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BYND\" target=\"_blank\">BYND</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464118-beyond-meat-rallies-after-tim-hortons-partnership-unveiled\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Beyond Meat rallies after Tim Hortons partnership unveiled</a></h4><ul> <li>Beyond Meat (NASDAQ:<a href='https://seekingalpha.com/symbol/BYND' title='Beyond Meat, Inc.'>BYND</a>) is <font color=\"green\">up 10.55%</font> and cruised earlier to a post-IPO high of $92.33.</li> <li>The company made another leap into the mainstream today when Tim Hortons said it would test plant-based sausage breakfast sandwiches at about 60 outlets around Toronto with an aim to go national across Canada.</li><li>The company's Beyond Burger products are also available in the meat case at Canadian retail outlets nationwide at Co-op Food Stores, Fresh Street Market, IGA, Loblaw and Longos.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3463926-tim-hortons-test-beyond-meat-sandwiches\" target=\"_blank\">Tim Hortons to test Beyond Meat sandwiches</a> (May 15)</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3464118\" data-linked=\"Beyond Meat rallies after Tim Hortons partnership unveiled\" data-tweet=\"$BYND - Beyond Meat rallies after Tim Hortons partnership unveiled https://seekingalpha.com/news/3464118-beyond-meat-rallies-after-tim-hortons-partnership-unveiled?source=tweet\" data-url=\"https://seekingalpha.com/news/3464118-beyond-meat-rallies-after-tim-hortons-partnership-unveiled\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>51&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464110\" data-ts=\"1557936489\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CJREF\" target=\"_blank\">CJREF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464110-corus-entertainmentminus-17_4-shaw-files-to-offer-80_6m-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Corus Entertainment -17.4% as Shaw files to offer 80.6M shares</a></h4><ul>   <li>Corus Entertainment (<a href='https://seekingalpha.com/symbol/CJREF' title='Corus Entertainment, Inc.B'>OTCPK:CJREF</a>) is <font color=\"red\">off 17.4%</font> as shareholder Shaw Communications has <a href=\"https://www.corusent.com/news/corus-entertainment-inc-announces-secondary-offering-of-class-b-non-voting-participating-shares/\" target=\"_blank\">filed to offer 80.6M shares</a>.</li>    <li>The shares are class B nonvoting shares, offered at a price of C$6.80 each to underwriters led by TD Securities. (They're quoting at C$6.66 currently in Toronto.)</li>    <li>Corus won't receive any proceeds from the offering; total gross proceeds are C$548.3M.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3464110\" data-linked=\"Corus Entertainment -17.4% as Shaw files to offer 80.6M shares\" data-tweet=\"$CJREF - Corus Entertainment -17.4% as Shaw files to offer 80.6M shares https://seekingalpha.com/news/3464110-corus-entertainmentminus-17_4-shaw-files-to-offer-80_6m-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3464110-corus-entertainmentminus-17_4-shaw-files-to-offer-80_6m-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>55&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464108\" data-ts=\"1557936127\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464108-westport-fuel-systems-and-lifeway-foods-among-consumer-gainers-coca-cola-consolidated-and\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Westport Fuel Systems and Lifeway Foods among consumer gainers; Coca-Cola Consolidated and Dean Foods in losers</a></h4><ul><li><b>Gainers: </b>Ocean Bio-Chem (NASDAQ:<a href='https://seekingalpha.com/symbol/OBCI' title='Ocean Bio-Chem, Inc.'>OBCI</a>) <font color=\"green\">+14%</font>. Beyond Meat (NASDAQ:<a href='https://seekingalpha.com/symbol/BYND' title='Beyond Meat, Inc.'>BYND</a>) <font color=\"green\">+11%</font>. IT Tech Packaging (NYSEMKT:<a href='https://seekingalpha.com/symbol/ITP' title='IT Tech Packaging, Inc.'>ITP</a>) <font color=\"green\">+8%</font>. Lifeway Foods (NASDAQ:<a href='https://seekingalpha.com/symbol/LWAY' title='Lifeway Foods, Inc.'>LWAY</a>) <font color=\"green\">+8%</font>. Westport Fuel Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/WPRT' title='Westport Fuel Systems Inc.'>WPRT</a>) <font color=\"green\">+8%</font>.</li><li><b>Losers: </b>Coca-Cola Consolidated (NASDAQ:<a href='https://seekingalpha.com/symbol/COKE' title='Coca-Cola Consolidated, Inc.'>COKE</a>) <font color=\"red\">-11%</font>. Dean Foods (NYSE:<a href='https://seekingalpha.com/symbol/DF' title='Dean Foods Company'>DF</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3464108\" data-linked=\"Westport Fuel Systems and Lifeway Foods among consumer gainers; Coca-Cola Consolidated and Dean Foods in losers\" data-tweet=\"$OBCI $BYND $ITP - Westport Fuel Systems and Lifeway Foods among consumer gainers; Coca-Cola Consolidated and Dean Foods in losers https://seekingalpha.com/news/3464108-westport-fuel-systems-and-lifeway-foods-among-consumer-gainers-coca-cola-consolidated-and?source=tweet\" data-url=\"https://seekingalpha.com/news/3464108-westport-fuel-systems-and-lifeway-foods-among-consumer-gainers-coca-cola-consolidated-and\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464105\" data-ts=\"1557935768\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TDG\" target=\"_blank\">TDG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464105-transdigm-ripped-for-gouging-taxpayers-in-congressional-hearing\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TransDigm ripped for &#39;gouging&#39; taxpayers in Congressional hearing</a></h4><ul><li>TransDigm (<a href='https://seekingalpha.com/symbol/TDG' title='TransDigm Group Incorporated'>TDG</a> <font color='red'>-3.7%</font>) tumbles as a Department of Defense official tells the House Committee on Oversight and Reform the company is \"<a href=\"http://fortune.com/2019/05/15/transdigm-pentagon-gouging/\" target=\"_blank\">gouging our taxpayers</a>\" with spare parts markups  that were as high as 4,451% and has repeatedly  declined to provide backup data on costs.</li><li>\"Once TransDigm refused to provide the requested cost data\" for at least  15 parts during 2015-17, \"our contracting officers were left with  the limited options\" of either buying the parts without receiving the  information or \"not buying the parts needed to meet mission  requirements,\" according to Kevin Fahey, assistant defense secretary for acquisition.</li><li>TDG is a \"bad actor\" that has \"built its long-term business  strategy on buying exclusive licenses or entire companies that  manufacture military-unique, high demand, low value parts for DoD  weapons systems and then drastically increasing the price of those  parts,\" Fahey says.</li><li>TDG CEO Kevin Stein says the company \"did nothing in contravention of the federal acquisition laws and regulations with respect to its pricing.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3464105\" data-linked=\"TransDigm ripped for &#39;gouging&#39; taxpayers in Congressional hearing\" data-tweet=\"$TDG - TransDigm ripped for &#39;gouging&#39; taxpayers in Congressional hearing https://seekingalpha.com/news/3464105-transdigm-ripped-for-gouging-taxpayers-in-congressional-hearing?source=tweet\" data-url=\"https://seekingalpha.com/news/3464105-transdigm-ripped-for-gouging-taxpayers-in-congressional-hearing\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464103\" data-ts=\"1557935651\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DOX\" target=\"_blank\">DOX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464103-stifel-pleased-amdocs-profit-beat-sharesplus-11_5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stifel pleased by Amdocs profit beat; shares +11.5%</a></h4><ul>   <li>Stifel says Amdocs (<a href=\"http://seekingalpha.com/symbol/DOX\" target=\"_blank\">DOX</a> <font color=\"green\">+11.5%</font>) made a \"solid start\" on regaining confidence after the company <a href=\"https://seekingalpha.com/news/3463687-amdocs-beats-0_03-revenue-line\" target=\"_blank\">topped profit expectations</a> yesterday amid customer and territory gains.</li>    <li>The company answered some hanging questions, including reducing unbilled receivables by $47M in a \"nice drop,\" analyst Tom Roderick says. Meanwhile, he's optimistic that AT&amp;T will re-accererate new business through the remaining two quarters of the fiscal year and into the next, after its run rate came in below expectations. (h/t Bloomberg)</li>    <li>He's got a Buy rating and a $70 price target, now implying 17.4% upside.</li>    <li><a href=\"https://seekingalpha.com/article/4264116-amdocs-limited-dox-ceo-shuky-sheffer-q2-2019-results-earnings-call-transcript\" target=\"_blank\">Earnings call transcript</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3464103\" data-linked=\"Stifel pleased by Amdocs profit beat; shares +11.5%\" data-tweet=\"$DOX - Stifel pleased by Amdocs profit beat; shares +11.5% https://seekingalpha.com/news/3464103-stifel-pleased-amdocs-profit-beat-sharesplus-11_5?source=tweet\" data-url=\"https://seekingalpha.com/news/3464103-stifel-pleased-amdocs-profit-beat-sharesplus-11_5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:54 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464100\" data-ts=\"1557935414\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADAP\" target=\"_blank\">ADAP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464100-adaptimmune-teams-up-alpine-to-develop-next-gen-cell-therapies\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Adaptimmune teams up with Alpine to develop next-gen cell therapies</a></h4><ul><li>Adaptimmune (<a href='https://seekingalpha.com/symbol/ADAP' title='Adaptimmune Therapeutics plc'>ADAP</a> <font color=\"green\">+3.7%</font>) will <a href=\"https://seekingalpha.com/pr/17513013-adaptimmune-alpine-immune-sciences-announce-collaboration-license-agreement-develop-next\" target=\"_blank\">collaborate </a>with Alpine Immune Sciences (<a href='https://seekingalpha.com/symbol/ALPN' title='Alpine Immune Sciences, Inc.'>ALPN</a> <font color=\"green\">+4.4%</font>) to develop next-generation SPEAR T-cell products based on the latter's secreted and transmembrane immunomodulatory protein (SIP and TIP) <a href=\"https://www.alpineimmunesciences.com/our-science/#immunotherapy\" target=\"_blank\">technology</a>.</li><li>A clinical trial evaluating the first candidate, ADP-A2M4CD8, should launch in H2.</li><li>Under the terms of the partnership, ADAP will pay ALPN an undisclosed upfront amount, research funding, up to $288M in milestones and low single-digit royalties on net sales. ADAP has the option to acquire a global license for each program.</li></ul><div class=\"tiny-share-widget\" data-id=\"3464100\" data-linked=\"Adaptimmune teams up with Alpine to develop next-gen cell therapies\" data-tweet=\"$ADAP $ALPN - Adaptimmune teams up with Alpine to develop next-gen cell therapies https://seekingalpha.com/news/3464100-adaptimmune-teams-up-alpine-to-develop-next-gen-cell-therapies?source=tweet\" data-url=\"https://seekingalpha.com/news/3464100-adaptimmune-teams-up-alpine-to-develop-next-gen-cell-therapies\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>39&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464097\" data-ts=\"1557935155\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EGHT\" target=\"_blank\">EGHT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464097-spending-outlook-for-8x8-worries-analysts-sharesminus-3_5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Spending outlook for 8x8 worries analysts; shares -3.5%</a></h4><ul>   <li>Comms firm 8x8 (NYSE:<a href='https://seekingalpha.com/symbol/EGHT' title='8x8, Inc.'>EGHT</a>) is <font color=\"red\">3.5% lower</font> during regular-session action after <a href=\"https://seekingalpha.com/news/3463695-comms-firm-8x8-minus-8_2-percent-losses-widen-higher-costs\" target=\"_blank\">reporting wider losses</a> in its fiscal Q4 earnings report, while an outlook for higher spending has brought concerns from analysts including a Dougherty downgrade.</li>    <li>The firm cut its rating to Neutral, considering the stock fairly valued and pulling its price target of $22 (the stock's at $22.90 today).</li>    <li>Elsewhere, Needham is \"frustrated\" with calls for higher costs without any bump to the company's revenue expectations. Q4 revenue is \"just shy of consensus\" amid an outlook for \"sharply higher spending,\" analyst Richard Valera says; he's rated Buy, though, with a price target of $25.</li>    <li>Meanwhile, the company today has announced an expansion for <a href=\"https://seekingalpha.com/pr/17513073-8x8-introduces-service-management-contact-centers-help-organizations-provide-best-class\" target=\"_blank\">contact center customers</a> with the launch of 8x8 Service Management for Contact Center.</li>    <li><a href=\"https://seekingalpha.com/article/4264113-8x8-inc-eght-ceo-vikram-verma-q4-2019-results-earnings-call-transcript\" target=\"_blank\">Earnings call transcript</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3464097\" data-linked=\"Spending outlook for 8x8 worries analysts; shares -3.5%\" data-tweet=\"$EGHT - Spending outlook for 8x8 worries analysts; shares -3.5% https://seekingalpha.com/news/3464097-spending-outlook-for-8x8-worries-analysts-sharesminus-3_5?source=tweet\" data-url=\"https://seekingalpha.com/news/3464097-spending-outlook-for-8x8-worries-analysts-sharesminus-3_5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:45 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464093\" data-ts=\"1557934239\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/POLA\" target=\"_blank\">POLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464093-polar-powerplus-3-post-q1-revenue-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Polar Power +3% post Q1 revenue beat</a></h4><ul><li>Polar Power (<a href='https://seekingalpha.com/symbol/POLA' title='Polar Power, Inc.'>POLA</a> <font color=\"green\">+3.7%</font>) reports Q1 sales growth of 59% Y/Y to $7.75M, driven by sales of DC power systems to Tier-1 telecommunications customers in the U.S.</li><li>Q1 Gross margin <font color=\"green\">improved by 42 bps</font> to 30.9%; and operating margin<font color=\"green\"> recovered by 773 bps</font> to 1%.</li><li>Q1 Operating expenses were $2.31M (+27.8% Y/Y), with selling &amp; marketing $630k (+3.2% Y/Y); R&amp;D $562.3k (+21.5% Y/Y); and G&amp;A $1.12M (+52.3% Y/Y).</li><li>Backlog was $14.16M at March 31, 2019.</li><li>Net cash used in operating activities was $1.98M, compared to $2.41M a year ago.</li><li>\u201cAs our revenues increase, we expect to increase our engineering staff to speed up new product development and provide a higher level of pre-sales support. We also expect to pursue R&amp;D contracts with the military. We believe diversification of sales into different markets will provide us with long term stable growth and improved gross margins\u201d, said Arthur Sams, CEO.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3463988-polar-power-beats-revenue\" target=\"_blank\">Polar Power beats on revenue</a> (May 15)</li></ul><div class=\"tiny-share-widget\" data-id=\"3464093\" data-linked=\"Polar Power +3% post Q1 revenue beat\" data-tweet=\"$POLA - Polar Power +3% post Q1 revenue beat https://seekingalpha.com/news/3464093-polar-powerplus-3-post-q1-revenue-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3464093-polar-powerplus-3-post-q1-revenue-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:30 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464095\" data-ts=\"1557934190\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INFN\" target=\"_blank\">INFN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464095-infineraplus-6-after-director-buys-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Infinera +6% after director buys shares</a></h4><ul><li>Infinera (NASDAQ:<a href='https://seekingalpha.com/symbol/INFN' title='Infinera Corporation'>INFN</a>)<font color=\"green\"> +6.4% </font>after board member Marcel Gani discloses buying 100K shares at an average price of $3.1479.</li></ul><div class=\"tiny-share-widget\" data-id=\"3464095\" data-linked=\"Infinera +6% after director buys shares\" data-tweet=\"$INFN - Infinera +6% after director buys shares https://seekingalpha.com/news/3464095-infineraplus-6-after-director-buys-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3464095-infineraplus-6-after-director-buys-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464089\" data-ts=\"1557933064\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464089-scripps-plans-next-gen-tv-standard-detroit-station\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Scripps plans next-gen TV standard at Detroit station</a></h4><ul>   <li>E.W. Scripps' (<a href=\"http://seekingalpha.com/symbol/SSP\" target=\"_blank\">SSP</a> <font color=\"red\">-3%</font>) WMYD station in Detroit will be among the first television stations to move to a <a href=\"https://seekingalpha.com/pr/17513292-scripps-wmyd-television-host-detroit-s-first-next-gen-television-station\" target=\"_blank\">next-generation broadcasting standard</a>.</li>    <li>The station will implement ATSC 3.0, an Internet Protocol-based platform made to easily deliver data to millions of receivers while mitigating online traffic jams.</li>    <li>At April's NAB Show, a coalition of station groups announced plans to deploy the standard in the 40 largest U.S. TV markets by the end of 2020, following testing/rollouts in Phoenix, Dallas, Baltimore, East Lansing, Raleigh, and Santa Barbara.</li>    <li>WDIV, owned by Graham Media Group (<a href=\"http://seekingalpha.com/symbol/GHC\" target=\"_blank\">GHC</a> <font color=\"green\">+0.5%</font>), will also take part in the next-gen launch in Detroit.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3464089\" data-linked=\"Scripps plans next-gen TV standard at Detroit station\" data-tweet=\"$SSP $GHC - Scripps plans next-gen TV standard at Detroit station https://seekingalpha.com/news/3464089-scripps-plans-next-gen-tv-standard-detroit-station?source=tweet\" data-url=\"https://seekingalpha.com/news/3464089-scripps-plans-next-gen-tv-standard-detroit-station\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464085\" data-ts=\"1557932575\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DCPH\" target=\"_blank\">DCPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464085-deciphera-perks-up-after-positive-ad-com-vote-on-daiichis-pexidartinib-for-tgct\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deciphera perks up after positive Ad Com vote on Daiichi&#39;s pexidartinib for TGCT</a></h4><ul><li>According to Instinet's Christopher Marai, Ph.D., yesterday's <a href=\"https://seekingalpha.com/news/3463871-daiichi-receives-opposite-votes-fda-ad-com-review-two-ndas\" target=\"_blank\">positive vote</a> from an FDA advisory committee on Daiichi Sankyo's CSF1R inhibitor pexidartinib for the treatment of tenosynovial giant cell tumors &#40;TGCT&#41; should bode well for Deciphera Pharmaceuticals (<a href='https://seekingalpha.com/symbol/DCPH' title='Deciphera Pharmaceuticals, Inc.'>DCPH</a> <font color=\"green\">+0.3%</font>).</li><li>DCTH is also developing a CSF1R inhibitor, Phase 1-stage <a href=\"https://www.deciphera.com/pipeline/\" target=\"_blank\">DCC-3014</a>, for the same indication. The estimated primary completion date of the <a href=\"https://clinicaltrials.gov/ct2/show/NCT03069469?intr=DCC-3014&amp;lead=deciphera&amp;rank=1\" target=\"_blank\">80-subject study</a> is November 2020.</li></ul><div class=\"tiny-share-widget\" data-id=\"3464085\" data-linked=\"Deciphera perks up after positive Ad Com vote on Daiichi&#39;s pexidartinib for TGCT\" data-tweet=\"$DCPH - Deciphera perks up after positive Ad Com vote on Daiichi&#39;s pexidartinib for TGCT https://seekingalpha.com/news/3464085-deciphera-perks-up-after-positive-ad-com-vote-on-daiichis-pexidartinib-for-tgct?source=tweet\" data-url=\"https://seekingalpha.com/news/3464085-deciphera-perks-up-after-positive-ad-com-vote-on-daiichis-pexidartinib-for-tgct\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464084\" data-ts=\"1557932505\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRM\" target=\"_blank\">CRM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464084-salesforceminus-1_5-analysts-see-q1-softness\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Salesforce -1.5% as analysts see Q1 softness</a></h4><ul><li>OTR Global says Salesforce (NYSE:<a href='https://seekingalpha.com/symbol/CRM' title='salesforce.com, inc.'>CRM</a>) is seeing \"less momentum\" in its Q1 and downgrades the stock from Positive to Mixed.</li><li>The firm sees limited upside and notes that customers appear \"more cautious than usual.\"</li><li>JMP Securities says its checks show that the \"overall business momentum was solid\" in the quarter, but parts of the strategic accounts team \"may have been quite underwhelming.\"</li><li>Salesforce <a href=\"https://seekingalpha.com/symbol/CRM/earnings\" target=\"_blank\">reports earnings</a> on June 4. Consensus estimates expect $3.68B in revenue and $0.61 EPS.</li><li>CRM shares are <font color=\"red\">down 1.5%</font> to $155.75.</li></ul><div class=\"tiny-share-widget\" data-id=\"3464084\" data-linked=\"Salesforce -1.5% as analysts see Q1 softness\" data-tweet=\"$CRM - Salesforce -1.5% as analysts see Q1 softness https://seekingalpha.com/news/3464084-salesforceminus-1_5-analysts-see-q1-softness?source=tweet\" data-url=\"https://seekingalpha.com/news/3464084-salesforceminus-1_5-analysts-see-q1-softness\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464080\" data-ts=\"1557932496\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464080-catalyst-pharmaceuticals-and-genetic-technologies-among-healthcare-gainers-immunogen-leads\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Catalyst Pharmaceuticals and Genetic Technologies among healthcare gainers; ImmunoGen leads the losers</a></h4><ul><li><b>Gainers: </b>PDS Biotechnology (NASDAQ:<a href='https://seekingalpha.com/symbol/PDSB' title='PDS Biotechnology Corporation'>PDSB</a>) <font color=\"green\">+37%</font>. Cellectar Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/CLRB' title='Cellectar Biosciences, Inc.'>CLRB</a>) <font color=\"green\">+33%</font>. Catalyst Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CPRX' title='Catalyst Pharmaceuticals, Inc.'>CPRX</a>) <font color=\"green\">+17%</font>. Genetic Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/GENE' title='Genetic Technologies Limited'>GENE</a>) <font color=\"green\">+16%</font>. Precipio (NASDAQ:<a href='https://seekingalpha.com/symbol/PRPO' title='Precipio, Inc.'>PRPO</a>) <font color=\"green\">+14%</font>.</li><li><b>Losers: </b>ImmunoGen (NASDAQ:<a href='https://seekingalpha.com/symbol/IMGN' title='ImmunoGen, Inc.'>IMGN</a>) <font color=\"red\">-30%</font>. Evofem Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/EVFM' title='Evofem Biosciences, Inc.'>EVFM</a>) <font color=\"red\">-18%</font>. electroCore (NASDAQ:<a href='https://seekingalpha.com/symbol/ECOR' title='electroCore, Inc.'>ECOR</a>) <font color=\"red\">-18%</font>. Outlook Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/OTLK' title='Outlook Therapeutics, Inc.'>OTLK</a>) <font color=\"red\">-14%</font>. Co-Diagnostics (NASDAQ:<a href='https://seekingalpha.com/symbol/CODX' title='Co-Diagnostics, Inc.'>CODX</a>) <font color=\"red\">-14%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3464080\" data-linked=\"Catalyst Pharmaceuticals and Genetic Technologies among healthcare gainers; ImmunoGen leads the losers\" data-tweet=\"$PDSB $CLRB $CPRX - Catalyst Pharmaceuticals and Genetic Technologies among healthcare gainers; ImmunoGen leads the losers https://seekingalpha.com/news/3464080-catalyst-pharmaceuticals-and-genetic-technologies-among-healthcare-gainers-immunogen-leads?source=tweet\" data-url=\"https://seekingalpha.com/news/3464080-catalyst-pharmaceuticals-and-genetic-technologies-among-healthcare-gainers-immunogen-leads\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464076\" data-ts=\"1557931872\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MKSI\" target=\"_blank\">MKSI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464076-mksplus-1_2-on-positive-start\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MKS +1.2% on Positive start</a></h4><ul><li>Susquehanna starts MKS Instruments (NASDAQ:<a href='https://seekingalpha.com/symbol/MKSI' title='MKS Instruments, Inc.'>MKSI</a>) at Positive with a $123 target, implying a 52% upside.</li><li>Last week, MKS <a href=\"https://seekingalpha.com/news/3461825-mks-instruments-minus-2-percent-ceo-transition\" target=\"_blank\">announced</a> a CEO transition that will take place on the first of next year.</li><li>MKSI shares are <font color=\"green\">up 1.2%</font> to $81.75.</li></ul><div class=\"tiny-share-widget\" data-id=\"3464076\" data-linked=\"MKS +1.2% on Positive start\" data-tweet=\"$MKSI - MKS +1.2% on Positive start https://seekingalpha.com/news/3464076-mksplus-1_2-on-positive-start?source=tweet\" data-url=\"https://seekingalpha.com/news/3464076-mksplus-1_2-on-positive-start\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464075\" data-ts=\"1557931802\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KIRK\" target=\"_blank\">KIRK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464075-kirklands-slumps-to-10-year-low\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kirkland&#39;s slumps to 10-year low</a></h4><ul> <li>Kirkland's (<a href='https://seekingalpha.com/symbol/KIRK' title='Kirkland&#39;s, Inc.'>KIRK</a> <font color='red'>-6%</font>) falls after B. Riley FBR downgrades the retailer to a Neutral rating from Buy on its view that a turnaround will take some time to play out.</li> <li>Kirkland's is also seen as one of the retail names in harm's way from a prolonged trade war between the U.S. and China.</li> <li>Shares of Kirkland's carved out a new 10-year low of $5.02 earlier in the session.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3464075\" data-linked=\"Kirkland&#39;s slumps to 10-year low\" data-tweet=\"$KIRK - Kirkland&#39;s slumps to 10-year low https://seekingalpha.com/news/3464075-kirklands-slumps-to-10-year-low?source=tweet\" data-url=\"https://seekingalpha.com/news/3464075-kirklands-slumps-to-10-year-low\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464074\" data-ts=\"1557931705\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLRB\" target=\"_blank\">CLRB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464074-cellectar-up-31-on-positive-clr-131-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cellectar up 31% on more positive CLR 131 data</a></h4><ul><li>Thinly traded nano cap Cellectar Biosciences (<a href='https://seekingalpha.com/symbol/CLRB' title='Cellectar Biosciences, Inc.'>CLRB</a> <font color=\"green\">+30.7%</font>) is up on a robust 32x surge in volume in reaction to <a href=\"https://seekingalpha.com/pr/17513144-clr-131-achieves-50-percent-overall-response-rate-cohort-6-ongoing-phase-1-study-relapsed\" target=\"_blank\">preliminary data</a> from Cohort 6 in its Phase 1 study of CLR 131 in patients with relapsed/refractory multiple myeloma.</li><li>Results showed a 50% partial response rate, a 50% minimal response rate and a 100% disease control rate (responders + stable cancer).</li><li>The company has initiated a seventh cohort at a higher dose. Interim data should be available in Q4.</li><li>CLR 131 is a phospholipid ether-drug conjugate &#40;PDC&#41; that selectively delivers radiation to malignant cancer cells.</li></ul><div class=\"tiny-share-widget\" data-id=\"3464074\" data-linked=\"Cellectar up 31% on more positive CLR 131 data\" data-tweet=\"$CLRB - Cellectar up 31% on more positive CLR 131 data https://seekingalpha.com/news/3464074-cellectar-up-31-on-positive-clr-131-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3464074-cellectar-up-31-on-positive-clr-131-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464073\" data-ts=\"1557931542\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RMBS\" target=\"_blank\">RMBS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464073-rambusplus-2-on-new-bull\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rambus +2% on new bull</a></h4><ul><li>Wells Fargo starts Rambus (NASDAQ:<a href='https://seekingalpha.com/symbol/RMBS' title='Rambus Inc.'>RMBS</a>) with an Outperform rating and a $15 price target, implying a 32% upside.</li><li>Rambus <a href=\"https://seekingalpha.com/news/3452585-rambus-minus-6-percent-surprise-q1-loss\" target=\"_blank\">reported earnings</a> late last month that included a surprise loss</li><li>RMBS shares are <font color=\"green\">up 2%</font> to $11.58.</li></ul><div class=\"tiny-share-widget\" data-id=\"3464073\" data-linked=\"Rambus +2% on new bull\" data-tweet=\"$RMBS - Rambus +2% on new bull https://seekingalpha.com/news/3464073-rambusplus-2-on-new-bull?source=tweet\" data-url=\"https://seekingalpha.com/news/3464073-rambusplus-2-on-new-bull\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:45 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464071\" data-ts=\"1557931294\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LAC\" target=\"_blank\">LAC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464071-lithium-americas-ceo-hodgson-retires-evans-will-take-charge\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lithium Americas CEO Hodgson retires; Evans will take charge</a></h4><ul><li>Lithium Americas (<a href='https://seekingalpha.com/symbol/LAC' title='Lithium Americas Corp.'>LAC</a> <font color=\"red\">-1.7%</font>) says CEO Tom Hodgson has <a href=\"https://seekingalpha.com/pr/17512784-lithium-americas-announces-retirement-tom-hodgson-appointment-jonathan-evans-chief-executive\" target=\"_blank\">retired</a> and will be replaced by current President and COO Jon Evans, effective immediately.</li><li>Evans joined LAC as President and COO last September after logging more than 20 years of executive operations, including serving as VP and GM of the Lithium Division at FMC Corp. (now Livent) and in management positions with General Electric.</li><li>Hodgson was Executive Chairman of LAC from pre-IPO to the merger with Western Lithium following a career in banking, finance and money management.</li></ul><div class=\"tiny-share-widget\" data-id=\"3464071\" data-linked=\"Lithium Americas CEO Hodgson retires; Evans will take charge\" data-tweet=\"$LAC - Lithium Americas CEO Hodgson retires; Evans will take charge https://seekingalpha.com/news/3464071-lithium-americas-ceo-hodgson-retires-evans-will-take-charge?source=tweet\" data-url=\"https://seekingalpha.com/news/3464071-lithium-americas-ceo-hodgson-retires-evans-will-take-charge\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464070\" data-ts=\"1557930962\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDB\" target=\"_blank\">MDB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464070-mongodbplus-4_7-on-new-street-high-target\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MongoDB +4.7% on new Street-high target</a></h4><ul><li>MongoDB (NASDAQ:<a href='https://seekingalpha.com/symbol/MDB' title='MongoDB, Inc.'>MDB</a>) <font color=\"green\">gains 4.7%</font> after Barclays raises its price target from $143 to $178 citing the steady core business growth and Atlas potential, which create \"a path to +$1bn in revenue by FY23.\"</li><li>The firm maintains an Overweight rating.</li></ul><div class=\"tiny-share-widget\" data-id=\"3464070\" data-linked=\"MongoDB +4.7% on new Street-high target\" data-tweet=\"$MDB - MongoDB +4.7% on new Street-high target https://seekingalpha.com/news/3464070-mongodbplus-4_7-on-new-street-high-target?source=tweet\" data-url=\"https://seekingalpha.com/news/3464070-mongodbplus-4_7-on-new-street-high-target\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464066\" data-ts=\"1557930914\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UQM\" target=\"_blank\">UQM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464066-on-uqm-technologies-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on UQM Technologies Q1 results</a></h4><ul><li>UQM Technologies (<a href='https://seekingalpha.com/symbol/UQM' title='UQM Technologies, Inc.'>UQM</a> <font color=\"green\">+0.3%</font>) reported Q1 revenues of $3.68M, an increase of 128.6% Y/Y.</li><li>Q1 Net loss widened to $2.47M, compared to $1.89M a year ago.</li><li>SG&amp;A expenses were $2.69M (+77.1% Y/Y); and R&amp;D expenses were $502.18K (-26% Y/Y).</li><li>Net cash used in operating activities was $1.39M, compared to $870.8k a year ago.</li><li>Company has Cash and cash equivalents of $2.91M as of March 31, 2019.</li><li>The acquisition by Danfoss A/S was approved by 69.65% of outstanding shares \u2013 such that 92.38% of total shares voted were in favor of the merger.</li><li>The transaction \u2013 at $1.71 per share, or ~$100M total valuation \u2013 is anticipated to close during 2Q19.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3463635-uqm-technologies-misses-0_03-misses-revenue\" target=\"_blank\">UQM Technologies misses by $0.03, misses on revenue</a> (May 14)</li></ul><div class=\"tiny-share-widget\" data-id=\"3464066\" data-linked=\"More on UQM Technologies Q1 results\" data-tweet=\"$UQM - More on UQM Technologies Q1 results https://seekingalpha.com/news/3464066-on-uqm-technologies-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3464066-on-uqm-technologies-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:35 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464069\" data-ts=\"1557930912\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HZNP\" target=\"_blank\">HZNP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464069-horizon-down-2-on-reported-negative-ruling-on-vimovo-patent\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Horizon down 2% on reported negative ruling on Vimovo patent</a></h4><ul><li>Horizon Therapeutics plc (<a href='https://seekingalpha.com/symbol/HZNP' title='Horizon Therapeutics Public Limited Company'>HZNP</a> <font color=\"red\">-1.7%</font>) slips on below-average volume in apparent response to reports of an adverse ruling on a patent covering <a href=\"https://www.vimovo.com/\" target=\"_blank\">Vimovo </a>(naproxen/esomeprazole magnesium), approved in the U.S. in May 2010 for arthritis patients at risk of developing NSAID-related gastric ulcers.</li><li>Vimovo accounted for 5% of the company's Q1 sales.</li></ul><div class=\"tiny-share-widget\" data-id=\"3464069\" data-linked=\"Horizon down 2% on reported negative ruling on Vimovo patent\" data-tweet=\"$HZNP - Horizon down 2% on reported negative ruling on Vimovo patent https://seekingalpha.com/news/3464069-horizon-down-2-on-reported-negative-ruling-on-vimovo-patent?source=tweet\" data-url=\"https://seekingalpha.com/news/3464069-horizon-down-2-on-reported-negative-ruling-on-vimovo-patent\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464065\" data-ts=\"1557930761\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464065-oil-inventories-build-sharply\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oil inventories build sharply</a></h4><ul><li><a href=\"http://ir.eia.gov/wpsr/wpsrsummary.pdf\" target=\"_blank\">EIA Petroleum Inventories</a>: Crude <strong>+5.4M</strong> barrels vs. -0.8M consensus, -4.0M last week.</li><li>Gasoline <strong>-1.1M</strong> barrels vs. -0.3M consensus, +0.6M last week.</li><li>Distillates <strong>+0.1M</strong> barrels vs. -1.0M consensus, -0.2M last week.</li><li>Futures <font color=\"red\">-0.66%</font> to $61.37.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Ultra Bloomberg Crude Oil ETF'>UCO</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BNO' title='The United States Brent Oil ETF, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/DBO' title='Invesco DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/USL' title='The United States 12 Month Oil ETF, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/SZO' title='DB Crude Oil Short ETN'>SZO</a>, <a href='https://seekingalpha.com/symbol/OLO' title='DB Crude Oil Long ETN'>OLO</a>, <a href='https://seekingalpha.com/symbol/OLEM' title='iPath Pure Beta Crude Oil ETN'>OLEM</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3464065\" data-linked=\"Oil inventories build sharply\" data-tweet=\"$USO $OIL $UCO - Oil inventories build sharply https://seekingalpha.com/news/3464065-oil-inventories-build-sharply?source=tweet\" data-url=\"https://seekingalpha.com/news/3464065-oil-inventories-build-sharply\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>60&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464063\" data-ts=\"1557930683\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLGX\" target=\"_blank\">CLGX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464063-corelogic-outlines-q2-charges-sharesplus-1_6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CoreLogic outlines Q2 charges; shares +1.6%</a></h4><ul><li>CoreLogic (NYSE:<a href='https://seekingalpha.com/symbol/CLGX' title='CoreLogic, Inc.'>CLGX</a>) <font color=\"green\">gains 1.6%</font> after <a href=\"https://seekingalpha.com/filing/4489638\" target=\"_blank\">revealing </a>it expects a non-cash impairment charge of approximately $45M to $50M in Q2 related to certain intangible and software assets of its appraisal management company, which is undergoing a transformation.</li><li>CLGX also expects cash charges of $10M to $12M primarily due to staff cuts.</li><li>The charges didn't impact the previously released quarterly and full-year guidance.</li></ul><div class=\"tiny-share-widget\" data-id=\"3464063\" data-linked=\"CoreLogic outlines Q2 charges; shares +1.6%\" data-tweet=\"$CLGX - CoreLogic outlines Q2 charges; shares +1.6% https://seekingalpha.com/news/3464063-corelogic-outlines-q2-charges-sharesplus-1_6?source=tweet\" data-url=\"https://seekingalpha.com/news/3464063-corelogic-outlines-q2-charges-sharesplus-1_6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:31 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464059\" data-ts=\"1557930588\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SLGG\" target=\"_blank\">SLGG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464059-super-league-gamingminus-3_7-post-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Super League Gaming -3.7% post Q1 results</a></h4><ul><li>Super League Gaming (<a href='https://seekingalpha.com/symbol/SLGG' title='Super League Gaming, Inc.'>SLGG</a> <font color=\"red\">-3.7%</font>) reported <a href=\"https://seekingalpha.com/pr/17512182-super-league-gaming-reports-first-quarter-2019-results\" target=\"_blank\">Q1</a> revenue growth 92.3% Y/Y to $0.25M, the increase was primarily driven by the emergence of our platform-as-a-service revenue stream.</li><li>Completion of IPO on February 27, 2019 with net proceeds of $22.5M.</li><li>At March 31, 2019, the Company\u2019s cash position totaled $21.5M, the increase was due to the net capital raised in the IPO.</li><li>All principal and interest related to the Company\u2019s convertible notes outstanding, totaling $13.8M, was automatically converted to equity upon the IPO close.</li><li>There is no debt outstanding as of March 31, 2019.</li><li>Also, appointed veteran media and gaming executive Mark Jung to the Super League board of directors.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3463653-super-league-gaming-misses-0_04-beats-revenue\" target=\"_blank\">Super League Gaming misses by $0.04, beats on revenue</a> (May. 14 2019)</li></ul><div class=\"tiny-share-widget\" data-id=\"3464059\" data-linked=\"Super League Gaming -3.7% post Q1 results\" data-tweet=\"$SLGG - Super League Gaming -3.7% post Q1 results https://seekingalpha.com/news/3464059-super-league-gamingminus-3_7-post-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3464059-super-league-gamingminus-3_7-post-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464047\" data-ts=\"1557929333\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PDSB\" target=\"_blank\">PDSB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464047-pds-bio-up-36-on-article-supporting-rationale-of-versamune\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PDS Bio up 36% on article supporting rationale of Versamune</a></h4><ul><li>Thinly traded nano cap PDS Biotechnology (<a href='https://seekingalpha.com/symbol/PDSB' title='PDS Biotechnology Corporation'>PDSB</a> <font color=\"green\">+36%</font>) is up on a healthy 22x surge in volume in response to results from a <a href=\"https://seekingalpha.com/pr/17513120-pds-biotechnology-announces-publication-supporting-novel-mechanisms-action-proprietary\" target=\"_blank\">preclinical study</a> supporting the value proposition of its <a href=\"http://www.pdsbiotech.com/versamune-platform/\" target=\"_blank\">Versamune </a>cancer immunotherapy platform. The data were published on May 3 in the online edition of the <em>Journal of Immunology</em> (it will appear in the June edition of the printed version).</li><li>The study showed the ability of Versamune to \"prime the immune system\" to overcome crucial mechanisms associated with ineffective immune response mediated by HPV16 and cancer cells, leading to a robust anti-tumor effect.</li><li>The company says it plans to confirm this activity in upcoming clinical studies of lead candidate <a href=\"http://www.pdsbiotech.com/pipeline/#pds-0101\" target=\"_blank\">PDS0101</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3464047\" data-linked=\"PDS Bio up 36% on article supporting rationale of Versamune\" data-tweet=\"$PDSB - PDS Bio up 36% on article supporting rationale of Versamune https://seekingalpha.com/news/3464047-pds-bio-up-36-on-article-supporting-rationale-of-versamune?source=tweet\" data-url=\"https://seekingalpha.com/news/3464047-pds-bio-up-36-on-article-supporting-rationale-of-versamune\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:08 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464029\" data-ts=\"1557927979\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LE\" target=\"_blank\">LE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464029-lampert-adds-to-lands-end-stake\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lampert adds to Lands&#39; End stake</a></h4><ul> <li>Lands' End (NASDAQ:<a href='https://seekingalpha.com/symbol/LE' title='Lands&#39; End, Inc.'>LE</a>) trades <font color=\"green\">2.22% higher</font> after Eddie Lampert reports holding a stake of 64.8% in the retailer through ESL Partners.</li> <li>Lampert's previous position was disclosed at 49.0%.</li> <li><a href=\"https://seekingalpha.com/filing/4490429\" target=\"_blank\">SEC Form 13D</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3464029\" data-linked=\"Lampert adds to Lands&#39; End stake\" data-tweet=\"$LE - Lampert adds to Lands&#39; End stake https://seekingalpha.com/news/3464029-lampert-adds-to-lands-end-stake?source=tweet\" data-url=\"https://seekingalpha.com/news/3464029-lampert-adds-to-lands-end-stake\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:46 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464028\" data-ts=\"1557927890\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IEF\" target=\"_blank\">IEF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464028-yield-curve-just-inverted-again\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">The yield curve just inverted again</a></h4><ul><li>The Fed has made clear it's sitting on its hands for now, but yields at the long end of the curve continue to plunge. The 10-year Treasury is down another four basis points this morning to 2.37% -<a href=\"https://twitter.com/lisaabramowicz1/status/1128649660804075526\" target=\"_blank\"> investors can earn a couple</a> of ticks more investing in 90-day bills.</li><li>It's not the first time the yield curve has inverted this year. Late March saw a brief inversion that was quickly reversed as a big rally in stocks led to a big rally in yields at the long end.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/IEF' title='iShares 7-10 Year Treasury Bond ETF'>IEF</a>, <a href='https://seekingalpha.com/symbol/PST' title='ProShares UltraShort 7-10 Year Treasury ETF'>PST</a>, <a href='https://seekingalpha.com/symbol/IEI' title='iShares 3-7 Year Treasury Bond ETF'>IEI</a>, <a href='https://seekingalpha.com/symbol/VGIT' title='Vanguard Intermediate-Term Treasury ETF'>VGIT</a>, <a href='https://seekingalpha.com/symbol/UST' title='ProShares Ultra 7-10 Year Treasury ETF'>UST</a>, <a href='https://seekingalpha.com/symbol/DTYS' title='iPath U.S. Treasury 10-Year Bear ETN'>DTYS</a>, <a href='https://seekingalpha.com/symbol/TYO' title='Direxion Daily 10-Year Treasury Bear 3x Shares ETF'>TYO</a>, <a href='https://seekingalpha.com/symbol/GSY' title='Invesco Ultra Short Duration ETF'>GSY</a>, <a href='https://seekingalpha.com/symbol/SCHR' title='Schwab Intermediate-Term U.S. Treasury ETF'>SCHR</a>, <a href='https://seekingalpha.com/symbol/STPP' title='iPath U.S. Treasury Steepener ETN'>STPP</a>, <a href='https://seekingalpha.com/symbol/FLAT' title='iPath U.S. Treasury Flattener ETN'>FLAT</a>, <a href='https://seekingalpha.com/symbol/TBX' title='ProShares Short 7-10 Year Treasury ETF'>TBX</a>, <a href='https://seekingalpha.com/symbol/TYD' title='Direxion Daily 10-Year Treasury Bull 3x Shares ETF'>TYD</a>, <a href='https://seekingalpha.com/symbol/ITE' title='SPDR Barclays Intermediate Term Treasury ETF'>ITE</a>, <a href='https://seekingalpha.com/symbol/DTYL' title='iPath U.S. Treasury 10-Year Bull ETN'>DTYL</a>, <a href='https://seekingalpha.com/symbol/HYDD' title='Direxion Daily High Yield Bear 2x Shares ETF'>HYDD</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3464028\" data-linked=\"The yield curve just inverted again\" data-tweet=\"$IEF $PST $IEI - The yield curve just inverted again https://seekingalpha.com/news/3464028-yield-curve-just-inverted-again?source=tweet\" data-url=\"https://seekingalpha.com/news/3464028-yield-curve-just-inverted-again\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>31&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464024\" data-ts=\"1557927594\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COTY\" target=\"_blank\">COTY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464024-insider-buying-coty\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Insider buying at Coty</a></h4><ul> <li>Coty (NYSE:<a href='https://seekingalpha.com/symbol/COTY' title='Coty Inc.'>COTY</a>) is <font color=\"green\">up 2.64%</font> after some insider buying action.</li> <li><a href=\"https://seekingalpha.com/filing/4490192\" target=\"_blank\">CEO Pierre Laubies</a> picked up 648K shares and CFO <a href=\"https://seekingalpha.com/filing/4490200\" target=\"_blank\">Pierre-Andre Terisse</a> snapped up 152K shares.</li> <li>The insider purchases arrived with shares of Coty already up 89% YTD.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3464024\" data-linked=\"Insider buying at Coty\" data-tweet=\"$COTY - Insider buying at Coty https://seekingalpha.com/news/3464024-insider-buying-coty?source=tweet\" data-url=\"https://seekingalpha.com/news/3464024-insider-buying-coty\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464009\" data-ts=\"1557926923\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEUM\" target=\"_blank\">TEUM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464009-pareteum-locks-down-70m-plus-in-april-sales-deals\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pareteum locks down $70M-plus in April sales deals</a></h4><ul>   <li>Pareteum (NASDAQ:<a href='https://seekingalpha.com/symbol/TEUM' title='Pareteum Corporation'>TEUM</a>) is touting more than <a href=\"https://seekingalpha.com/pr/17512819-pareteum-achieves-70-million-new-sales-agreements-april\" target=\"_blank\">$70M in new sales deals</a> for April, across more than 20 new transactions.</li>    <li>That includes a now-usual list of communications providers (including MVNOs in EMEA, Hong Kong and the U.S.), along with airlines and pharmaceutical manufacturers, and a Japanese communications and IoT service provider.</li>    <li>Shares are <font color=\"green\">up 1.8%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3464009\" data-linked=\"Pareteum locks down $70M-plus in April sales deals\" data-tweet=\"$TEUM - Pareteum locks down $70M-plus in April sales deals https://seekingalpha.com/news/3464009-pareteum-locks-down-70m-plus-in-april-sales-deals?source=tweet\" data-url=\"https://seekingalpha.com/news/3464009-pareteum-locks-down-70m-plus-in-april-sales-deals\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464008\" data-ts=\"1557926857\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TDOC\" target=\"_blank\">TDOC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464008-teladoc-slips-2-premarket-on-accreditation-issue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Teladoc slips 2% premarket on accreditation issue</a></h4><ul><li>Teladoc Health (NYSE:<a href='https://seekingalpha.com/symbol/TDOC' title='Teladoc Health, Inc.'>TDOC</a>) is down <font color=\"red\">2%</font> premarket on light volume in apparent response to reports that its NCQA accreditation is under corrective action.</li></ul><div class=\"tiny-share-widget\" data-id=\"3464008\" data-linked=\"Teladoc slips 2% premarket on accreditation issue\" data-tweet=\"$TDOC - Teladoc slips 2% premarket on accreditation issue https://seekingalpha.com/news/3464008-teladoc-slips-2-premarket-on-accreditation-issue?source=tweet\" data-url=\"https://seekingalpha.com/news/3464008-teladoc-slips-2-premarket-on-accreditation-issue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464005\" data-ts=\"1557926827\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464005-acb-and-among-premarket-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ACB and A among premarket losers</a></h4><ul><li>ImmunoGen (NASDAQ:<a href='https://seekingalpha.com/symbol/IMGN' title='ImmunoGen, Inc.'>IMGN</a>) <font color=\"red\">-31%</font>.</li><li>Sunworks (NASDAQ:<a href='https://seekingalpha.com/symbol/SUNW' title='Sunworks, Inc.'>SUNW</a>) <font color=\"red\">-23%</font>.</li><li>Co-Diagnostics (NASDAQ:<a href='https://seekingalpha.com/symbol/CODX' title='Co-Diagnostics, Inc.'>CODX</a>) <font color=\"red\">-13%</font>.</li><li>INSYS Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/INSY' title='INSYS Therapeutics, Inc.'>INSY</a>) <font color=\"red\">-10%</font>.</li><li>Agilent Technologies (NYSE:<a href='https://seekingalpha.com/symbol/A' title='Agilent Technologies, Inc.'>A</a>) <font color=\"red\">-10%</font>.</li><li>Uniti Group (NASDAQ:<a href='https://seekingalpha.com/symbol/UNIT' title='Uniti Group Inc.'>UNIT</a>) <font color=\"red\">-9%</font>.</li><li>JinkoSolar Holding (NYSE:<a href='https://seekingalpha.com/symbol/JKS' title='JinkoSolar Holding Co., Ltd.'>JKS</a>) <font color=\"red\">-7%</font>.</li><li>Tata Motors (NYSE:<a href='https://seekingalpha.com/symbol/TTM' title='Tata Motors Limited'>TTM</a>) <font color=\"red\">-7%</font>.</li><li>Fuel Tech (NASDAQ:<a href='https://seekingalpha.com/symbol/FTEK' title='Fuel Tech, Inc.'>FTEK</a>) <font color=\"red\">-7%</font>.</li><li>Aurora Cannabis (NYSE:<a href='https://seekingalpha.com/symbol/ACB' title='Aurora Cannabis Inc.'>ACB</a>) <font color=\"red\">-6%</font>.</li><li>Virtu Financial (NASDAQ:<a href='https://seekingalpha.com/symbol/VIRT' title='Virtu Financial, Inc.'>VIRT</a>) <font color=\"red\">-6%</font>.</li><li>SAExploration Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/SAEX' title='SAExploration Holdings, Inc.'>SAEX</a>) <font color=\"red\">-6%</font>.</li><li>8x8 (NYSE:<a href='https://seekingalpha.com/symbol/EGHT' title='8x8, Inc.'>EGHT</a>) <font color=\"red\">-5%</font>.</li><li>The Children's Place (NASDAQ:<a href='https://seekingalpha.com/symbol/PLCE' title='The Children&#39;s Place, Inc.'>PLCE</a>) <font color=\"red\">-5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3464005\" data-linked=\"ACB and A among premarket losers\" data-tweet=\"$IMGN $SUNW $CODX - ACB and A among premarket losers https://seekingalpha.com/news/3464005-acb-and-among-premarket-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3464005-acb-and-among-premarket-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3464003\" data-ts=\"1557926639\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3464003-adxs-clrb-among-premarket-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ADXS, CLRB among premarket gainers</a></h4><ul><li>Appliance Recycling Centers of America (NASDAQ:<a href='https://seekingalpha.com/symbol/ARCI' title='Appliance Recycling Centers of America, Inc.'>ARCI</a>) <font color=\"green\">+19%</font> on <a href=\"https://seekingalpha.com/news/3464000-appliance-recycling-centers-america-reports-q1-results\" target=\"_blank\">Q1 earnings</a>.</li><li>PDS Biotechnology (NASDAQ:<a href='https://seekingalpha.com/symbol/PDSB' title='PDS Biotechnology Corporation'>PDSB</a>) <font color=\"green\">+12%</font> on <a href=\"https://seekingalpha.com/news/3463691-pds-biotechnology-reports-q1-results\" target=\"_blank\">Q1 earnings</a>.</li><li>The Container Store (NYSE:<a href='https://seekingalpha.com/symbol/TCS' title='The Container Store Group, Inc.'>TCS</a>) <font color=\"green\">+11%</font> on <a href=\"https://seekingalpha.com/news/3463644-container-store-beats-0_03-beats-revenue\" target=\"_blank\">Q1 earnings</a>.</li><li>Advaxis (NASDAQ:<a href='https://seekingalpha.com/symbol/ADXS' title='Advaxis, Inc.'>ADXS</a>) <font color=\"green\">+11%</font> as FDA or Agencyhas <a href=\"https://seekingalpha.com/pr/17512893-fda-lifts-partial-clinical-hold-phase-3-aim2cerv-study-axalimogene-filolisbac\" target=\"_blank\">lifted</a> the partial clinical hold on AIM2CERV, the company\u2019s Phase 3 clinical trial of axalimogene filolisbac for the treatment of patients with high-risk locally advanced cervical cancer.</li><li>Cellectar Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/CLRB' title='Cellectar Biosciences, Inc.'>CLRB</a>) <font color=\"green\">+7%</font> as CLR 131 <a href=\"https://seekingalpha.com/pr/17513144-clr-131-achieves-50-percent-overall-response-rate-cohort-6-ongoing-phase-1-study-relapsed\" target=\"_blank\">achieves 50%</a> overall response rate in cohort 6 of ongoing phase 1 study.</li><li>PPDAI Group (NYSE:<a href='https://seekingalpha.com/symbol/PPDF' title='PPDAI Group Inc.'>PPDF</a>) <font color=\"green\">+6%</font> on <a href=\"https://seekingalpha.com/news/3463825-ppdai-group-beats-0_14-beats-revenue\" target=\"_blank\">Q1 earnings</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3464003\" data-linked=\"ADXS, CLRB among premarket gainers\" data-tweet=\"$JAN $PDSB $TCS - ADXS, CLRB among premarket gainers https://seekingalpha.com/news/3464003-adxs-clrb-among-premarket-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3464003-adxs-clrb-among-premarket-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:23 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3463998\" data-ts=\"1557926373\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TAK\" target=\"_blank\">TAK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3463998-takeda-f18-top-line-up-19-eps-down-53\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Takeda F18 top line up 19%; EPS down 53%</a></h4><ul><li>Takeda Pharmaceutical Company (NYSE:<a href='https://seekingalpha.com/symbol/TAK' title='Takeda Pharmaceutical Company Limited'>TAK</a>) <a href=\"https://seekingalpha.com/pr/17510540-takeda-reports-fy2018-full-year-results-issues-fy2019-guidance\" target=\"_blank\">fiscal 2018 results</a> (billion yen):</li><li>Revenue: 2,097.2 (+18.5%); operating profit: 205.0 (-15.2%); net income: 109.1 (-41.6%); core earnings: 459.3 (+42.4%); EPS: 113 yen (-52.6%).</li><li>Legacy Takeda: Revenue: 1,788.0 (+1.0%); operating profit: 411.8 (+70.3%); net income: 312.9 (+67.4%); core earnings: 393.3 (+21.9%); EPS: 399 yen (+66.6%).</li><li><strong>Fiscal 2019 guidance </strong>(billion yen): Revenue: 3,300.0 (+57.4%); operating profit: (193.0); net income: (383.0); EPS: (246 yen); core earnings: 883.0 (+92.2%).</li><li>Shares are up <font color=\"green\">1%</font> premarket on light volume.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3463239-takeda-pharmaceutical-reports-fy-results\" target=\"_blank\">Takeda Pharmaceutical reports FY results</a> (May 14)</li></ul><div class=\"tiny-share-widget\" data-id=\"3463998\" data-linked=\"Takeda F18 top line up 19%; EPS down 53%\" data-tweet=\"$TAK - Takeda F18 top line up 19%; EPS down 53% https://seekingalpha.com/news/3463998-takeda-f18-top-line-up-19-eps-down-53?source=tweet\" data-url=\"https://seekingalpha.com/news/3463998-takeda-f18-top-line-up-19-eps-down-53\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:19 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3463997\" data-ts=\"1557926315\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3463997-zillow-gains-on-offers-based-upgrade-guggenheim\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zillow gains on Offers-based upgrade at Guggenheim</a></h4><ul>   <li>Zillow Group is higher premarket (<a href='https://seekingalpha.com/symbol/Z' title='Zillow Group, Inc.'>Z</a> <font color=\"green\">+2.3%</font>, <a href='https://seekingalpha.com/symbol/ZG' title='Zillow Group, Inc.'>ZG</a> <font color=\"green\">+2.2%</font>) following an upgrade to Buy at Guggenheim, pointing to the company's <a href=\"https://seekingalpha.com/news/3463039-zillow-launches-offers-minnesotas-twin-cities\" target=\"_blank\">growing Offers business</a>.</li>    <li>\"It may take years to fully realize the vision,\" writes analyst Jake Fuller, but recent results show \"that demand for Offers is real, unit profits are possible.\" The ad business has significant value as well, Fuller says. (h/t Bloomberg)</li>    <li>He's set a $45 price target on <a href='https://seekingalpha.com/symbol/ZG' title='Zillow Group, Inc.'>ZG</a>, implying 23% upside.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3463997\" data-linked=\"Zillow gains on Offers-based upgrade at Guggenheim\" data-tweet=\"$Z $ZG - Zillow gains on Offers-based upgrade at Guggenheim https://seekingalpha.com/news/3463997-zillow-gains-on-offers-based-upgrade-guggenheim?source=tweet\" data-url=\"https://seekingalpha.com/news/3463997-zillow-gains-on-offers-based-upgrade-guggenheim\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3463987\" data-ts=\"1557925475\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AN\" target=\"_blank\">AN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3463987-eddie-lampert-boosts-stake-in-autonation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eddie Lampert boosts stake in AutoNation</a></h4><ul> <li>AutoNation (NYSE:<a href='https://seekingalpha.com/symbol/AN' title='AutoNation, Inc.'>AN</a>) tracks higher after Eddie Lampert discloses he boosted his stake in the retailer to 17.1% from 12.9%.</li> <li>Shares of AutoNation are <font color=\"green\">up 0.88%</font> premarket to $39.52.</li> <li><a href=\"https://seekingalpha.com/filing/4490369\" target=\"_blank\">SEC Form 13D</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3463987\" data-linked=\"Eddie Lampert boosts stake in AutoNation\" data-tweet=\"$AN - Eddie Lampert boosts stake in AutoNation https://seekingalpha.com/news/3463987-eddie-lampert-boosts-stake-in-autonation?source=tweet\" data-url=\"https://seekingalpha.com/news/3463987-eddie-lampert-boosts-stake-in-autonation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:04 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3463986\" data-ts=\"1557925409\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DGLY\" target=\"_blank\">DGLY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3463986-digital-ally-beats-0_21-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Digital Ally beats by $0.21, beats on revenue</a></h4><ul><li>Digital Ally (NASDAQ:<a href='https://seekingalpha.com/symbol/DGLY' title='Digital Ally, Inc.'>DGLY</a>): Q1 GAAP EPS of -$0.29 <font color=\"green\">beats by $0.21</font>.</li><li>Revenue of $2.55M (+3.2% Y/Y) <font color=\"green\">beats by $0.25M</font>.</li><li>Shares <font color=\"green\">+6%</font> PM.</li><li><a href=\"https://seekingalpha.com/pr/17513370-digital-ally-inc-announces-2019-first-quarter-operating-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3463986\" data-linked=\"Digital Ally beats by $0.21, beats on revenue\" data-tweet=\"$DGLY - Digital Ally beats by $0.21, beats on revenue https://seekingalpha.com/news/3463986-digital-ally-beats-0_21-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3463986-digital-ally-beats-0_21-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}